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Do not attempt to do a thing unless you are sure of yourself; 
but do not relinquish it simply because someone else is not sure of you 
(Stewart E. White) 
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BACKGROUND 
The use of light for therapeutic purposes reaches far back in time. Current interest for 
photomedicine with his its biological and medical effects relies fundamentally on two 
major evolutions in the given field; (1) the research results regarding the use of 
ultraviolet (UV) radiation by the end of the 19th century and (2) the developments in 
the light amplification by stimulated emission of radiation (laser)-technology. The production 
of the first laser, the ruby pulsed laser, was rapidly succeeded by the development of 
the helium-neon laser and other lasers like the argon, the neodymium-glass and the 
neodymium-yttrium-aluminium-garnet lasers.1  
As in the mid-1990s semiconductor and diode-based lasers gained popularity the 
principally massive gas and dye lasers were rendered obsolete. Therapeutic light 
technology further continued to evolve and today’s therapeutic light source is as likely 
to be a light emitting diode (LED) or polarized light as a semiconductor or diode 
laser.1 
Technological advancement and variation of the light sources necessitate a 
concomitant update and revision of research in the respective domains of application. 
Unfortunately this logical and rational necessity has rarely been fulfilled. From a 
historical perspective this lack of appropriate research has led to disenchanting 
evolutions in the use of light, especially in physiotherapy. The experience exists in this 
medical field that light sources were promoted and commercialised for a vast regimen 
of indications without foregoing scientific backup. Consequently research developed 
often after the commercial introduction in physiotherapy. As these investigations 
frequently gave rise to conflicting results for certain indications, scepticism arose and 
the use of the given modality knew a waning popularity for all its indications. The final 
result of such an inappropriate frame of promotion, commercialisation, and research is 
a growing clinical disuse of a given modality even for motivated indications. In view of 
the actual increasing interest in LED treatment and based on former ascertainment, 
one has to state that a literature review for the given source reveals that research 
mostly covers only low level laser (LLL) studies.2,3 Although, recently a number of 
papers can be noted that report on the effects of LEDs and polarized light; still 
 4 
numerous source-specific-questions need to be answered, as research concerning 
mechanisms of action and efficacy of the current light sources remains limited in view 
of a substantiated clinical application.4-17 
 
The reason for the contemporary light-oriented interest in physiotherapeutic practice 
for LED devices is in essence based on several advantages of LED in comparison with 
LLL. For example: the use of LEDs is esteemed to be safer as the delivered power 
does not damage tissue, LEDs can be made to produce multiple wavelengths, thereby 
stimulating outright a broader range of tissue types, and probes that cover a large 
treatment area are available.18 In addition, from a commercial point of view LEDs are 
far more interesting, as they are a good deal cheaper than laser diodes and they have a 
long life span as these solid devices stand robust handling. 
 
As a result of the above-mentioned lack of literature on LED some providers of these 
devices have taken for granted that the biological response of tissue to light irradiation 
cannot be equated merely to a light source. They declare that a given response solely 
depends on the extent of absorption of radiated light by the tissue.19 Consequently 
these providers state that it is acceptable to extrapolate scientific findings of LLL 
studies for explaining the mechanisms of action and detailing the efficacy of LED and 
other alternative light sources. Thus actually without appropriate scientific support 
equal biological effects are attributed to LED as to LLL. Nevertheless, prudence is 
called for such an extrapolation, firstly because it is irrespective of the mentioned 
dissimilarities and by simple projection one ignores a number of physical differences 
between LLL and LED (e.g.: coherence and degree of collimation or divergence). 
Secondly LLL therapy is still not yet an established and evidence-based clinical tool.20 
Notwithstanding the historical efforts, there still remains a considerable amount of 
ignorance, scepticism and controversy concerning the use and clinical efficacy of 
LLL.3,21-26 This ascertainment can be attributed to the broad spectrum of proposed 
parameters for irradiation, as well as to the difficult objective measurement of possible 
irradiation effects and even to the exceptional range of unsubstantiated indications for 
General introduction 
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which light therapy was promoted.27-29 A lack of theoretical understanding can also be 
responsible for the existing controversies, as the evaluation and interpretation of 
research results would be simplified largely when the appropriate knowledge about the 
mechanisms of light action would be available.  
LLL literature can undoubtedly be used as basis for research on LED and as a 
comparative reference for these given investigations. However, to guarantee evidence-
based use of LED within physiotherapy the need for specific research in view of an 
accurate consumption of LED is definite, especially for potential promising clinical 
applications in physiotherapy: according to LLL literature mainly wound healing and 
analgesia.30,31 
 
Hitherto, the most substantial research concerning the use of LED for improvement 
of wound healing is provided by Whelan and colleagues.18,32-34 As healing is retarded 
under the influence of prolonged exposure to microgravity (e.g. during long-term space 
flights) and in case of absence of exposure to sunlight, such as in submarine 
atmospheres, they performed wound healing experiments for military application in the 
given circumstances.32,33 In vitro experiments revealed that LED treatment increased 
proliferation of 3T3 fibroblasts and L6 rat skeletal muscle cell lines, doubled DNA 
synthesis in LED treated fibroblasts, and accelerated growth rate of fibroblasts and 
osteoblasts during the initial growing phase.18,32,33 Animal in vivo wound healing studies 
demonstrated therapeutic benefits of LED in speeding the early phase of wound 
closure and in changing gene expression in a type 2 diabetic mouse model.18,32,34 
Human studies noted 50% faster healing of lacerations, a return of sensation, and 
increased tissue granulation as a result of LED irradiation.18,33 
 
Associates of the Rehabilitation Sciences Research Group of the Ulster University in 
Northern Ireland extensively investigated the effectiveness of light in the treatment of 
pain. The emphasis was laid primarily on the analysis of the effects of various low level 
laser light sources.35-44 However, in the year 2001, two studies gave an account on the 
efficacy of non-laser sources, the so-called multisource diode arrays.45,46 Noble et al46 
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noticed relatively long-lasting neurophysiological effects: a significant change of the 
nerve conduction characteristics (decrease of the negative peak latency) was mediated 
by a monochromatic multisource infrared diode device. Glasgow et al45 suggested that a 
comparable multisource diode device was ineffective in the management of delayed-
onset of muscle soreness (DOMS). 
 
Despite the major value of these described trials, a definitive answer regarding the 
ability of LED in influencing wound healing or pain is not forthcoming; cardinally 
because a number of aspects are not yet investigated. Consequently more research is 
required in order to avoid inaccurate use of LED. As inaccuracy leads inevitable to the 
formerly mentioned scepticism regarding the effectiveness of a medium and possibly 
to the undeserved fall into disuse of the treatment modality which happened in a way 
with LLL therapy. 
 
PHYSICAL CHARACTERISTICS 
This chapter supplies a short, but comprehensive review of opto-physics. A brief 
description of the physical characteristics of the LED source used is essential, as the 
physical properties of light play an important part in the ultimate efficacy of treatment.  
 
According to the International Electrotechnical Commission (IEC 60825-1), an LED 
can be defined as:  
Any semiconductor p-n junction device which can be made to produce electromagnetic radiation by 
radiative recombination in the wavelength range of 180 nm to 1 mm, produced primarily by the process 
of spontaneous emission.19,47  
 
The LED device used for this doctoral thesis is depicted in figure 1 (BIO-DIO 
preprototype, MDB-Laser, Belgium). This illustration shows that a probe consists of 
32 single LEDs disseminated over a surface of 18 cm2.  
General introduction 
 7
Figure 1: LED device and three available probes (infrared, red, and green) 
 
Three highly monochromatic probes were available, each emitting light of a different 
wavelength within the above-defined range (table 1).27,48 The wavelength of the light 
emitted, and thus its colour, depends on the band gap energy of the materials forming 
the p-n junctiona. This light property is a key determinant to obtain maximum 
photochemical or biological responses, as light absorption by tissue molecules is 
wavelength specific.27 Only by absorbing radiation of the appropriate wavelength 
(namely the wavelengths equal to the energy states of the valence electrons) 
photoacceptor molecules will be stimulated, resulting in a direct photochemical 
reaction.28,48,49 The wavelengths of radiation that a molecule can absorb, the so-called 
                                              
a A p-n junction is the interface at which a p-type semiconductor (dominated by positive electric 
charges) and n-type semiconductor (dominated by negative electric charges) make contact with each 
other. The application of sufficient voltage to the semiconductor results in a flow of current, allowing 
electrons to cross the junction into the p region. When an electron moves sufficiently close to a 
positive charge in the p region, the two charges re-combine. For each recombination of a negative and 
a positive charge, a quantum of electromagnetic energy is emitted in the form of a photon of light.4,47,50 
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absorption spectrum of a particular molecule, is limited; absorption often only occurs 
over a waveband range of about 40-60 nm.27,48,51 Nevertheless, the absorption 
spectrum at cell or tissue level is broad because cells are composed of many different 
molecules. 
Besides its influence on the absorption by means of tissue molecules, there is a crucial 
link between wavelength and penetration depth of the irradiated light. Penetration into 
tissue decreases as the wavelength shortens; hence green light penetrates less than red 
light, which at his turn penetrates less into tissue than infrared light.27,48 Detailed 
principles of light penetration will be discussed below. 
 
The LED device used emits non-coherent light. In the 1980s, the observed biological 
responses after laser irradiation were generally thought to be attributable to the 
coherenceb of the light.48,52,53 Though, currently the clinical and biological significance 
of coherence is seriously questioned.54 According to several authors coherence does 
not play an essential role in laser-tissue interactions; firstly as it was proven that both 
coherent and non-coherent light clinically show equal efficacy.7,55,56 Secondly, as 
according to some authors, almost immediately after transmission of light through the 
skin coherence is lost, due to refraction and scattering.28,29,48 Nevertheless Tuner et 
al19,57 state that both findings are incorrect; coherence is not lost in tissue due to the 
phenomenon of scattering and non-coherent light is not as efficient as coherent light. 
This lack of consensus makes it necessary to mention whether or not light is 
coherent.27,58  
Further decisive characteristics to accomplish phototherapeutic efficacy are the power, 
exposure time, output mode, and beam area. Based on these parameters both 
irradiancec and radiant exposured can be calculated. According to numerous authors 
some of these parameters are more crucial than others to determine whether 
                                              
b Coherence is a term describing light as waves which are in phase in both time and space. 
Monochromaticity and low divergence are two properties of coherent light.48 
c Irradiance can be defined as the intensity of light illuminating a given surface. The radiometric unit of 
measure is W/m2 or factors there of (mW/cm2).48 
d The radiant exposure is a function of irradiance and exposure time, thus it is a measure of the total 
radiant energy applied to an area; the unit of measure is J/cm2.48 
General introduction 
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absorption of light will lead to a photobiological event.19,27,28,48,54,55 However, the 
literature yields several controversial findings as not all authors attribute an equal 
importance to a given parameter. For example, according to Nussbaum et al59 
irradiance was the determinant characteristic in the biomodulation of Pseudomonas 
aeruginosa rather than the expected radiant exposure. Moreover, van Breugel et al49 
found that, in order to stimulate tissue cell proliferation a specific combination of 
irradiance and exposure time are more important than the actual radiant exposure. Low 
et al39,40, on the contrary, highlighted the critical importance of the radiant exposure in 
observing neurophysiological effects. Whereas Mendez et al60 reported that both 
parameters influence the final results of light therapy.  
Koutna et al61 even suggested that the output mode of light applications plays a more 
prominent role in the treatment outcome than the wavelength of the used light source. 
Nevertheless, this finding could not be confirmed by other research results. Besides, 
more controversial findings have been published regarding the output mode; although 
the repetition rate in a pulsed mode was considered as an important treatment 
parameter, several investigations failed to prove its value.19,27,28,40,41,44,61-64  
Based on these findings it was opted within the investigations of this doctoral thesis to 
irradiate in a continuous mode. The remaining dosimetric parameters (wavelength, 
exposure time, and power) depended on the purpose of each investigation; they are 
described in the respective chapters. The data necessary for the calculation of the 
radiant exposure for the equipment used in the respective trials are summarized in 
table 1. 
 
 
 
 
 
 
 
 
Table 1: Wavelength and power-range properties of the three available LED 
probes 
 Wavelength (nm) Power (mW) 
  Low Medium  High 
Infrared 950 80 120 160 
Red 660 15 46 80 
Green 570 0.2 4.2 10 
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The radiant exposure of the used LED can be calculated as follows65: 
 
  
RE = 
 
Radiant Exposure [J/cm2] 
  T = Treatment time [min] 
  P = Power [mW] (see table 1) 
  S = Square irradiated zone[18 cm2] 
 
 
P
RE = α  S T 
 α =  
{ 0.06 (continuous mode) or  0.03 (pulsed mode) 
 
 
The parameters commented on so far, can be considered as the external dosimetry; 
involving all parameters directly controlled by the operator, limited by the apparatus 
used. Furthermore, there is the so-called internal dosimetry, referring to (1) several 
physical phenomena (reflection, transmission, scattering, and absorption) influencing 
the light distribution within the tissue during energy transfer, (2) the optical 
characteristics of the irradiated tissue, as well as (3) the relation between the external 
dosimetry and these respective elements.54,66 
This internal dosimetry determines to a considerable extend the penetration of light 
into tissue. Penetration can be defined as the tissue depth at which the radiant 
exposure is reduced to 37% of its original value.19,48 However, this definition only 
accounts for the absolute penetration depth resulting in direct effects of light at that 
depth. In addition, there is also a relative penetration depth leading up to effects 
deeper in the irradiated tissue and even in certain degree throughout the entire 
body.19,67 These so-called systemic effects can be caused by chemical processes initiated 
at superficial levels, at their turn mediating effects at a deeper tissue level.57 
Involvement of several forms of communication in the tissue such as blood circulation 
and transport of transmitters or signal substances is possible.19,67 This means that light 
sources with poor absolute penetration do not necessarily give inferior results than 
those with a good absolute penetration.19 
In the same context, it should be noted that calculation and even measurement of the 
exact light distribution during irradiation is highly complicated; principally as tissues 
have complex structures and also because the optical properties of tissues vary largely 
inter-individual.27,68 
General introduction 
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Studies regarding actual penetration depth of LED light are scarce, consequently the 
knowledge on the topic of penetration depth of LED light is based on literature 
originating from LLL research.19 These findings, established with various LLL sources, 
revealed that there is an obvious relation between penetration depth and 
wavelength.27,48,67,69-71 
 
Three final remarks can be made on the dosimetry. First of all, it should be noted that 
partly as a result of the above-mentioned contrasting findings on dosimetry, ideal light 
source characteristics for effective treatment of various medical applications are not yet 
established and probably never really will be.28 Therefore, in the attempt to offer 
sufficient guidelines for correct use of treatment parameters, one should always try to 
provide detailed description of light source properties used in any trial; so the 
practitioner can interpret the scientific results adequately and accordingly draw the 
correct conclusions for his clinical practice.  
A second comment is based on the mentioned possible influence of the external and 
internal dosimetric parameters on the photobiological effectiveness of light, the 
intrinsic target tissue sensitivity, the wavelength specificity of tissue, and the relation 
between radiated wavelength and penetration depth.19,54,65,72 So it should be 
emphasized that caution is recommended when comparing research results of light 
sources with different wavelengths or other dissimilar dosimetric parameters. 
A third and final remark considers the extrapolation issue. Comparison of the 
therapeutic usefulness of the same light source used on different species should occur 
cautiously. So simply extrapolating the dosage used for one species to another is 
inadvisable; in addition direct conversion of dosimetry from in vitro research to in vivo 
clinical practice is inappropriate. So, purposive and specific research is the prerequisite 
to produce safe and correct use of light as a therapeutic modality.27 
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MECHANISMS OF ACTION 
In the past decennia, several mechanisms of action for biostimulation and pain 
inhibition have been proposed and investigated.73 Research was primarily based on 
studies at the molecular and cellular levels and as a second resort investigations 
occurred at the organism level; resulting in numerous possible explanatory 
mechanisms.27,28,58 
It is the common view that light triggers a cascade of cellular and molecular reactions 
resulting in various biological responses. Thus, different mechanisms of whom the 
causal relationships are very difficult to establish- underlie the effects of light.34,48,55,74,75 
To illustrate this complex matter, the various mechanisms of action will be summarised 
by means of a comprehensive model (fig 2). Detailed discussion about the different 
individual components of the proposed model and other effects than those regarding 
wound healing or analgesia were not provided as this was beyond the scope of this 
general introduction. 
 
As depicted in figure 2, exposure to light leads to photon absorption by a 
photoacceptor molecule, causing excitation of the electronic state or increased 
vibrational state of the given molecule.27,51,73 This process is followed by primary 
photochemical reactions.74,75 Several key mechanisms have been discussed in the 
literature. Respiratory chain activation is the central point and can occur by an 
alteration in redox properties, acceleration of electron transfer, generation of reactive 
oxygen species (namely singlet oxygen formation and superoxide generation), as well as 
by induction of local transient heating of absorbing chromophores.19,28,48,51,55,76-83 It is 
supposed that each of these respective mechanisms plays a part in obtaining a 
measurable biological effect. It is yet not clear if one mechanism is more prominent 
and decisive than another, nevertheless recent experimental evidence has revealed that 
mechanisms based on changes in redox properties of terminal enzymes of respiratory 
chains might be of crucial importance.28,48,51,76,79 
The primary mechanisms occurring during light exposure are followed by the dark 
reactions (secondary mechanisms), occurring when the effective radiation is switched 
General introduction 
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off.28,51 Activation of respiratory chain components is followed by the initiation of a 
complicated cellular signalling cascade or a photosignal transduction and amplification 
chain, associated with e.g. changes in the cellular homeostasis, alterations in ATP or 
cAMP levels, modulation of DNA and RNA synthesis, membrane permeability 
alterations, alkalisation of cytoplasm, and cell membrane depolarisation.28,32,51,55,71,84-87 
The sequence of events finally results in a range of physiological effects essential for 
the promotion of the wound healing process, for supplying analgesia, or other 
advantageous responses (acceleration of inflammatory processes, oedema re-
absorption, increased lymph vessel regeneration or increased nerve 
regeneration).12,18,19,27,48,61,88-93  
Photostimulation of the wound healing process can be mediated by increased 
fibroblast proliferation, enhanced cell metabolism, increased (pro)collagen synthesis, 
and transformation of fibroblasts into myofibroblasts.19,27,61,73,79,85,94-98 Investigations 
have been especially focussed on fibroblasts, but other possible physiological effects 
attributing to an accelerated wound healing were also observed: suppression and 
alteration of undesirable immune processes, increased leukocyte activity, new 
formation of capillaries, increased production of growth factors and enzymes, while 
monocytes and macrophages can provide an enlarged release of a variety of substances 
related to immunity and wound healing.16,19,27,73,76 
As pain and nociception are even less understood than wound healing, the possible 
mechanisms in obtaining pain relief by the use of light are less underpinned. However 
it is established that light therapy influences the synthesis, release, and metabolism of 
numerous transmitter signal substances involved in analgesia such as endorphin, nitric 
oxide, prostaglandin, bradykinin, acetylcholine, and serotonin. In addition to these 
neuropharmacological effects there is experimental evidence for diminished 
inflammation, decreased C-fibre activity, increased blood circulation, and reduced 
excitability of the nervous system.19,27,84,88,99 
One should be aware that a large amount of research regarding the possible 
mechanisms of light action was conducted at the cellular level. The described cascade 
of reactions at the organism level is possibly even more complex as, in contradiction to 
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the in vitro situation, in vivo a range of supplementary interactions can influence the 
sequence of effects and accordingly the final responses. Besides, it needs to be 
mentioned that this summary did not take into account the origin of the light or the 
external dosimetry, thus the description is based on investigations performed with 
various light sources and different dosages.  
Figure 2: Model summarizing the identified mechanisms of light action  
Secondary
mechanisms
Primary 
mechanisms
Final effects
Trigger
Stimulated 
wound healing Analgesia 
Exposure to light  
Photon absorption by photoacceptors  
Respiratory chain 
activation 
Accelerated electron
transfer 
Reactive oxygen 
generation 
Heating of absorbing 
chromophores 
Altered redox 
properties
↓ inflammation 
↑ oedema resorption 
↑ lymph vessel regeneration
↑ blood circulation 
Photosignal transduction and amplification chain  
↑ fibroblast proliferation 
↑ cell metabolism 
↑ collagen synthesis  
↑ myofibroblast transformation 
↑ release of growth factors 
↑ release of enzymes 
↑ capillary formation 
↓ C-fibre activity 
↓ nervous excitability 
neuropharmacological effects
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Regardless of the large number of previous investigations, identification of underlying 
mechanisms of light action remains an important issue as these are not yet fully 
understood, and because probably not all mechanisms of action are currently 
identified. Convincing explanation of the mechanisms, in normal as well as in 
pathological tissue, could banish the existing suspicion concerning the use of light as a 
treatment modality.27,32,54,76,78 
 
AIMS AND OUTLINE 
The introduction of LED in medicine and in physiotherapy more specifically requires 
particular scientific research, especially within the fields of its clinical potential 
application: wound healing and analgesia. The above described gaps in literature 
regarding the use of LED laid the foundation of this doctoral thesis. 
Consequently the general purpose of this thesis is to explore a scientific approach for 
the supposed biostimulatory and analgesic effect of LED and to formulate an answer 
in view of an evidence-based clinical use of this treatment modality.  
 
The detailed objectives can be phrased as follows:  
 
 
Aim 1: To assess the biostimulatory effectiveness of LED 
irradiation under normal in vitro conditions.  
Aim 2: To investigate the value of LED treatment to ameliorate 
in vitro cell proliferation under conditions of impaired healing. 
Aim 3: To examine the effectiveness of LED in changing the 
nerve conduction characteristics in view of analgesia. 
Aim 4: To determine the efficacy of LED irradiation as an 
analgesic treatment modality in a laboratory setting. 
 
Part I investigates the influence of LED on wound healing. In pursuit of the first aim, 
chapter 1 reports the results of a twofold study. The first part consisted of an in vitro trial 
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measuring fibroblast proliferation with a Bürker hemocytometer. Proliferation of these 
cells needs to be considered as an exponent of the wound healing process, as 
fibroblasts fulfil a crucial role in the late inflammatory phase, the granulation phase, 
and early remodelling.100 Secondly an in vivo case study, exploring the postulation that 
LED irradiation could accelerate and ameliorate the healing of a surgical incision, was 
described. 
The results contrasted sharply with the findings of the in vitro part. Two fundamental 
causes were proposed in order to explain the different biological effect of LED 
irradiation observed in vitro and in vivo: the used irradiation parameters and evaluation 
method. 
The experiment described in chapter 2 endeavoured to explore these considerations. A 
similar study was therefore performed; but as distinctive characteristics different light 
source properties, an adapted irradiation procedure and the use of a colorimetric assay, 
based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), for the 
counting of the cells, were used. 
 
As stimulation of the wound healing process is virtually mainly indicated under 
conditions of impaired healing (resulting in a situation which threatens to become 
chronic and debilitating), proper attention for this matter is warranted.19,28,55 Besides 
the medical consequences, the costs involved with impaired healing yield also a socially 
relevant problem to tackle. Impaired healing will become even more common as the 
world population continues to age. After all senescence of systems and age-committed 
comorbid conditions are commonly the culprits responsible for poor wound healing.101 
Thus finding cost-effective, time-sparing, non-invasive, and practical treatment 
modalities to cure wounds is a necessity. 
Aiming to assess the biostimulative effects by means of LED in these circumstances, a 
third study was conducted with respect of the previous results regarding irradiation 
parameters and cell proliferation analysis. The irradiation experiment, described in 
chapter 3, analysed the fibroblast cultivation in medium supplemented with glucose. 
This medium modification serves as a pattern for cell proliferation in diabetic patients, 
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a population for whom stimulation of the wound healing process is a clinical relevant 
feature. 
 
In part II the potential analgesic effects of LED treatment (aim 3 and 4) were explored 
by means of two studies. A first investigation (chapter 4) evaluated the influence of LED 
on the sensory nerve conduction characteristics of a human superficial peripheral 
nerve; as a potential explanatory mechanism of pain inhibition by LED which is based 
on the putative neurophysiological effects of this treatment modality. The experimental 
hypothesis postulated that LED generates an immediate decrease in conduction 
velocity and increase in negative peak latency. In addition, it was postulated that this 
effect is most prominent immediately after the irradiation and will weaken as time 
progresses.  
The values of nerve conduction velocity and negative peak latency of a baseline 
antidromic nerve conduction measurement were compared with the results of five 
identical recordings performed at several points of time after LED irradiation.  
 
Chapter 5 illustrates a study assessing the analgesic efficiency of LED in a laboratory 
setting. To guarantee an adequate standardized and controlled pain reduction study, 
there was opted to observe a healthy population with experimentally induced DOMS. 
Induction of DOMS has been described in a number of studies as a representative 
model of musculoskeletal pain and stiffness, because it can be induced in a relatively 
easy and standardised manner, the time course is quite predictable, and the symptoms 
have the same aetiology and are of transitory nature.44,45,102-105 
The treatment as well as the assessment procedure was performed during 4 
consecutive days. The first day, isokinetic exercise was performed to induce pain 
related to DOMS. Subsequently the volunteers of the experimental group received an 
infrared LED treatment and those of the placebo group received sham-irradiation. 
Evaluation of the effect of the treatment on perceived pain was registered by a visual 
analog scale and by a mechanical pain threshold; these observations occurred every day 
 18 
prior to and following LED irradiation. Eccentric/concentric isokinetic peak torque 
assessment took place daily before each treatment. 
For the analysis of the results three different factors were taken into consideration: 
time (day 1, 2, 3, and 4), pre-post (preceding or following LED irradiation), and group 
(placebo or experimental). 
 
In completion of this thesis, the most prominent findings are summarized and the 
clinical implications are discussed. The general discussion also includes some future 
research directions and a final conclusion. 
General introduction 
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ABSTRACT 
Variable effects of different forms of light therapy on wound healing have been 
reported. This preliminary study covers the efficacy of infrared light emitting diodes 
(LED) in this domain.  
Cultured embryonic chicken fibroblasts were treated in a controlled, randomised 
manner. LED irradiation was performed three consecutive days with a wavelength of 
950 nm and a power output of 160 mW, at 0.6 cm distance from the fibroblasts. Each 
treatment lasted 6 minutes, resulting in a surface energy density of 3.2 J/cm2.  
The results indicated that LED treatment does not influence fibroblast proliferation at 
the applied energy density and irradiation frequency (p=0.474). 
Meanwhile the effects of LED on wound healing in vivo were studied by treating a 
surgical incision (6 cm) on the lateral side of the right foot of a male patient. The 
treatment started after 13 days, when initial stitches were removed. The same 
parameters as the in vitro study were used but the treatment was performed five times. 
The healing could only be evaluated clinically, the irradiated area (2.6 cm) showed a 
more appropriate contraction, less discoloration and a less hypertrophic scar than the 
control area (3.4 cm).  
The used parameters failed to demonstrate any biological effect of LED irradiation in 
vitro, although the case study on the other hand illustrated a beneficial effect. 
 
Keywords: Light Emitting Diodes · Fibroblasts · Wound healing 
From an in vitro trial to a patient treatment 
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INTRODUCTION 
Various beneficial effects of lasers and photodiodes at relatively low intensities have 
been reported, involving treatment of neurological impairments1,2, treatment of pain3-5, 
treatment of soft tissue injuries6,7, wound healing8-10 et cetera. In particular, the 
enhancement of wound healing has been a focus of contemporary research11-16. It 
seems a logic tendency while according to Baxter17 Photobiostimulation of wound healing 
remains the cardinal indication for therapeutic laser in physiotherapy, he concluded this on the 
basis of a questionnaire about low power laser (LPL) in the current clinical practice in 
Northern Ireland18.  Cambier et al19 confirmed these findings in a comparable survey 
into clinical LPL experience in Flanders. 
Nevertheless, there remains a considerable amount of ignorance, scepticism and 
controversial issues concerning the use and clinical efficacy of LPL, even in the domain 
of wound healing12,15,20,21. This is at least in part a consequence of the inability to 
measure and control operating variables related to connective tissue repair and of the 
wide range of suitable parameters for irradiation. 
Thus LPL therapy is not yet an established clinical tool11 as LPLs have some inherent 
characteristics which make their use in a clinical setting problematic, including 
limitations in wavelength capabilities and beam width. The combined wavelength of 
light optimal for wound healing cannot be efficiently produced, and the size of 
wounds, which may be treated by LPLs, is limited. Some companies offer an 
alternative to LPLs by introducing light emitting diodes (LED’s). These diodes can be 
made to produce multiple wavelengths, and can have probes with large surface area 
allowing treatment of large wounds. Still one can not accept this light source as an 
alternative for LPL therapy based on the cited advantages without proper investigation 
regarding its biostimulatory effects. 
The effectiveness of this possible alternative for LPLs must be studied in vitro and in 
addition in animal models or in humans because the effects of LED at the cellular level 
do not necessarily translate to a noticeable effect in vivo. The small amount of previous 
investigations demonstrate that LED effects are as difficult to isolate16,22,23 as LPL 
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effects and the results are conflicting, just like the results in literature specific on the 
use of LPL12,15,20. 
 
The purpose of the first part of this study is to examine the hypothesis stating that 
LED irradiation can influence fibroblast proliferation. Therefore, a comparison of the 
proliferation from fibroblasts in irradiated and control wells was performed. The in vitro 
investigation was linked with an in vivo case study. This part enquired the assumption if 
LED irradiation could accelerate and ameliorate the healing of a surgical incision. 
 
IN VITRO INVESTIGATION 
MATERIALS AND METHODS 
The complete procedure, from isolation to proliferation analysis, was executed twice 
(trial A and B). Trial A involved 30 irradiated petri dishes and the same number of 
control dishes. The second trial consisted of 27 irradiated and 27 control dishes.   
 
Cell isolation and culture procedures 
Primary fibroblast cultures were initiated from 8-days old chicken embryos. Isolation 
and disaggregating of the cells occurred with warm trypsin (N.V. Life Technologies, 
Belgium) according the protocol described by Ian Freshney (1994)24. The primary 
explants were cultivated at 37°C in Hanks’ culture Medium (N.V. Life Technologies, 
Belgium) supplemented with 10% Fetal Calf Serum (Invitrogen Corporation, UK),1% 
Fungizone (N.V. Life Technologies, Belgium), 1% L-Glutamine (N.V. Life 
Technologies, Belgium) and 0.5% Penicillin-Streptomycin (N.V. Life Technologies, 
Belgium). When cell growth from the explants reached confluence, cells were detached 
with trypsine and subcultured during 2 days in 80-cm2 culture flasks (Nunc, N.V. 
Life Technologies, Belgium) with 12 ml of primary culture medium. After 24 hours the 
cells were removed from the culture flasks by trypsinization and counted by 
hemocytometry. Secondary subcultures were initiated in 21.5 cm2 petriplates (Nunc, 
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N.V. Life Technologies, Belgium). The fibroblasts were seeded at a density of 
70.000/cm2, resulting in 1.505.000  cells per well. After adding 5 ml primary culture 
medium the cells were allowed to attach for 24 hours in a humidified incubator at 
37°C. 
 
Properties of the Light Emitting Diode 
Prior to LED treatment, all dishes were microscopically checked to guarantee that the 
cells are adherent, and to assure that there is no confluence, nor contamination. The 
dishes were divided randomly into the treated or the control group. Medium was then 
removed by tipping the dishes and aspirating with a sterile pipette. Following the 
aspiration, 2 ml fresh medium was added and treatment started. 
A Light Emitting Diode (LED) device (BIO-DIO preprototype, MDB-Laser, 
Belgium), with a wavelength of 950 nm (power-range, 80-160 mW; frequency-range, 0-
1500 Hz) was used. The surface of the LED probe was 18 cm2 and it consisted of 32 
single LED’s. For the treatments in this study an average power of 160 mW at 
continuous mode was applied. The irradiation lasted 6 minutes, resulting in an energy 
density of 3.2 J/cm2. The distance to the fibroblasts numbered 0.6 cm and as a result 
of the divergence in function of this distance, the surface of the LED (18 cm2) covered 
the complete surface of the used petriplates (21.5 cm2).  
After these manipulations, 3 ml medium was added to each dish followed by 24 hours 
incubation. 
One LED irradiation was performed daily, during three consecutive days according 
this procedure. Control cultures underwent the same handling, during these three days, 
but were sham-irradiated. 
 
Proliferation analysis 
After the last treatment, a trypsination was performed, to detach the cells from the 
culture dishes, followed by centrifugation. Once the cells were isolated from the used 
trypsine, they were resuspended in 4 ml fresh medium. The number of fibroblasts 
Chapter 1 
 32
within this suspension, as reflection for the proliferation, was quantified by means of a 
Bürker Chamber, or hemocytometry. 
The counting of the cells involved, amalgamating 200 µl Trypan blue (0.1 %, Sigma-
Aldrich Corporation, UK) and 100 µl cell suspension in an Eppendorf (Elscolab, 
Belgium). Approximately 40 µl of this suspension (cells/Trypan blue) was pipetted on 
the edge of the coverslip from the Bürker Chamber. Finally a blinded investigator 
using an inverted light microscope counted the number of cells in 25 small squares. 
In order to calculate the number of cells, one should multiply the amount of cells 
counted in the Bürker Chamber with the volume of 25 small squares (10.000 mm3) and 
the dilution factor (the amount of Trypan blue suspended with the cells, 2/1=3). 
 
Statistical methods 
The data were analysed statistical in order to examine the hypothesis that LED 
irradiation enhances fibroblast proliferation. They were processed as absolute figures 
for both trials separately. In a second phase the counted cell numbers were converted 
in relative figures so the data of both trials could be analysed as the data of one test. 
These relative figures were obtained by expressing each figure as a percentage from the 
highest figure (=100%) of that trial and this for each assay separately. 
A Kolmogorov-Smirnoff test of normality was performed on the data, followed by a 
Mann-Whitney-U test when the test of normality was significant and otherwise a T-
test. Differences were accepted as significant when p<0.05. For this analysis SPSS® 
10.0 was used. 
 
RESULTS 
The descriptive data for both trials are depicted in figure I. The mean number of cells 
in trial A is higher than in trial B for the controls as for the treated wells. There is a 
mean difference of 1.252.500 fibroblasts between the controls and 1.223.000 between 
the irradiated wells of trial A and B. The averages of both trials show that in control 
cultures there are slightly more fibroblasts than in the treated cultures. Nevertheless, no 
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statistically significant difference could be found between the two groups in either trial, 
nor in the combined data. The test of normality (Kolmogorov-Smirnoff) was not 
significant for trial A (p=0.20) nor trial B (p=0.20). Only the combined data from both 
trials were significant (p<0.01) for normality. Further analysis, respectively T-test for 
the single trials (trial A: p=0.412; trial B: p=0.274) or Mann-Whitney-U test for the 
combined data (p=0.474), revealed no statistical significant differences. 
 
DESCRIPTIVE DATA
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Figure I: Mean number of fibroblasts within control and irradiated wells for trail A and B  
 
DISCUSSION 
Biostimulatory effectiveness of lasers and photodiodes at relatively low intensities 
(<500 mW) in vitro have been analysed by evaluating various factors, involving 
(pro)collagen production25-27, cell viability28,29, growth factor production28 and 
myofibroblast formation30. Fibroblast proliferation also is an important factor to 
consider. In accordance with wound healing fibroblasts fulfil an essential role especially 
in the late inflammatory phase and the early granulation phase31. Despite the failure of 
some studies to demonstrate beneficial effects of LPL irradiation on fibroblast 
proliferation (determined by cell counting)32,33, Webb et al34 provided evidence of very 
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significantly higher cell numbers in irradiated wells (with an increase ranging from 8.9 - 
20.8 %). Atabey et al35 also revealed a significant increase in cell number; two or more 
irradiations resulted in an increased fibroblast proliferation. Several other studies 
confirmed these positive findings25,26,36,37. 
The results of this present in vitro study, indicate that LED treatment does not 
influence fibroblast proliferation. Although the dosimetric parameters (in particular the 
arbitrary energy density of 3.2 J/cm2) used in this study are well within the 
recommended limits (energy density: 0.077 J/cm2 – 7.3 J/cm2) described in previous 
studies about LPL therapy, raising enhanced fibroblast proliferation25,26,34-37. 
Van Breugel et al36 gave a possible explanation for these controversial results. 
According to them the fibroblast proliferation is not inherent at the energy density. 
They provide evidence that, independent of the energy density, the power density and 
the exposure time determine the biostimulative effects of LPL irradiation. LPL with a 
power below 2.91 mW could enhance cell proliferation while a higher power had no 
effect. 
Some authors also argued that the absorption spectrum of human fibroblasts show 
several absorption peaks and pointed out that a wavelength of 950 nm is far above the 
highest peak of about 730 nm36,38. At longer wavelengths they determined a general 
decrease in absorption. Despite these results, several investigators pose biostimulative 
effects on fibroblast cell processes by using LPLs with a wavelength of 830 nm27,39 or 
even 904 nm25,26. Loevschall et al29 note the absorption spectrum from fibroblasts is 
ranged from 800 nm to 830 nm; principally because of the presence of cytochrome 
oxidase in the cells. Furthermore, the supposed superior absorption of the fibroblasts 
at lower wavelengths is restricted by an inferior skin transmission than at higher 
wavelengths38.  
Beside the used probe, the Bio-Dio has a 570 nm and a 660 nm probe, emitting 
respective green and red light. The 950 nm beam of light was used for its high power 
density, but according to a range of remarks mentioned above, the effects of the two 
other probes must be as well evaluated. 
From an in vitro trial to a patient treatment 
 35
Another factor one can not ignore is that besides fibroblast proliferation other 
processes or morphologic changes were not analysed, although several authors have 
posed that those changes and processes could be responsible for the biostimulative 
effect of low power light resulting in enhanced wound healing17. Pourreau-Schneider et 
al30 for example described a massive transformation of fibroblasts into myofibroblasts 
after LPL treatment. These modified fibroblasts play an important role in contraction 
of granulation tissue30. A second example is an increased (pro)collagen production 
after low power light therapy25-27, which is also considered as a responsible factor for 
accelerated wound healing25-27,36 and is often unrelated to enhanced fibroblast 
proliferation36,40. 
It may be wondered if the light sources, mostly LPL, in the consulted literature are 
representative for the LED used in this study, although this LPL literature is often 
used for that purpose. As in the early days of LPL, the stimulative effects upon 
biological objects were explained by its coherence, the beam emitted by the Bio-Dio on 
the contrary produces incoherent light. Nowadays contradictory research results are 
responsible for a new discussion: the clinical and biological significance of coherence. 
The findings of some authors17,23,41-43 pose that the coherence of light is of no 
importance of LPL and its effects, although the opposite has also been stated44,45. 
Therefore it is unclear whether the property ‘incoherence’ of the LED can be 
accounted for the non-enhanced fibroblast proliferation in this trial. 
Another possible explanation for the absence of biostimulative effect is related to the 
moment of analysis of the proliferation. The evaluation one day after the last 
irradiation did not allow a delayed enhancement of proliferation; while it is determined 
in numerous investigations that the effects occur more than 24 hours after the last 
treatment27,37,46 and that they weaken after a further undefined period of time34.  
The fluctuation in cell numbers between both trials, despite the use of an identical 
protocol, was remarkable. Hallman et al33 noticed comparable fluctuations due to poor 
reproducibility of their technique. In this study the fluctuations are attributable to the 
counting of the cells by Bürker hemocytometer before seeding. According to some 
authors Bürker hemocytometer is not sufficiently sensitive47, it suffers from large 
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variability48 and it is often difficult to standardize48. Overestimation of the cell 
concentration also occurs with Bürker hemocytometer49. The insufficient sensitivity 
was contradicted by Lin et al50, moreover satisfactory correlations with flow-
cytometer48 and  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay 
for cell counting (MTT)51 were determined. 
An automated counter can be a reliable alternative to the Bürker hemocytometer as it 
provides accurate cell counts in a short period of time with less intervention from the 
investigator52. 
These remarks and controversies point out the possible deficiencies from the used 
proliferation analyses and the relativity from the obtained results. Other analyse 
methods and analyses from different cell processes and morphologic changes could be 
considered for further investigation.  
 
IN VIVO INVESTIGATION 
MATERIALS AND METHODS 
The effects of LED on wound healing in vivo were studied by treating a postsurgical 
incision. A male patient received chirurgical treatment for the removal of a cyst, 
situated approximately 1.5 cm posterior from the lateral malleolus of his right foot. For 
removal of the cyst an incision of 6 cm was made. The incision was sutured and 12 
days after the surgery the stitches were removed. Visual inspection demonstrated that 
the healing process of the wound proceeded well but not equally over the whole 6 
centimetres (figure II). Epithelialization and wound contraction appeared to have 
progressed better in the upper part (approximately 3 cm) of the cicatrice than at the 
lower part (covered with eschar). No evidence of infection was noted in either part. 
LED treatment started the 13th day. The incision was treated partially, the lowest part 
(2.6 cm), with the inferior epithelialization and wound contraction was irradiated, the 
remaining 3.4 cm served as control area. This control area was screened from radiation 
with cardboard and opaque black cling film. 
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The light source, destinated for the treatment, was the same device used for the in vitro 
irradiation, namely the BIO-DIO, a Light Emitting Diode from MDB-Laser. LED 
output parameters were identical with those applicated in the preceding in vitro 
investigation. In particular a continuous wave at an average power of 160 mW and 6 
minutes of treatment duration, corresponding to an energy density of 3.2 J/cm2. An 
equal distance from the probe to the target tissue as from the probe to the culture 
medium was respected.  A plastic applicant of according height guaranteed constant 
distance of 0.6 cm from the surface of the skin. 
Figure II: Surgical incision before the first treatment, 13 days after initial stitching 
 
Therapy was performed once a day during five consecutive days, repeatedly at the same 
time, resulting in an extension of the duration of the in vitro therapy with two days.  
Visual macroscopic observations were accomplished 6, 52 and 175 days after the first 
treatment.  
Comparison of the cutaneous sensitivity at the irradiated area and the control area was 
accomplished with a Semmes-Weinstein aesthesiometer (Smith & Nephew Rolyan) 175 
days after the first treatment. A control measurement also occurred at the same region 
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on the left foot. The aesthesiometer used in this study consisted of five hand-held 
nylon monofilaments with a length of 38 mm and varying diameter. 
Sensitivity threshold is traced by presenting a monofilament of a certain diameter 
vertically to the skin. The monofilament bends when a specific pressure has been 
reached with a velocity proportional to its diameter. Measurements allow mapping 
areas of sensitivity loss and assessing the degree of loss. Sensitivity levels are classified 
from ‘normal sensitivity’ attributed when the patient is able to discriminate the smallest 
filament  (0.0677 grams) over ‘diminished light touch’ (0.4082 grams), ‘diminished 
protective sensation’ (2.0520 grams) and ‘loss of protective sensation’ (3.632 grams) to 
finally ‘untestable’ (447.0 grams) when the patient did not respond to any of the 
filaments. 
 
RESULTS 
Visual estimation at any point of time after irradiation divulged no occurrence of 
problems with dehiscence or infection in either part of the wound. During the five 
days of therapy, the irradiated area looked dryer than the control area. After the last 
irradiation this was no longer recorded. 
 
Figure III: Surgical incision 6 days after initiating LED 
treatment. The lower 2.6 cm was irradiated, the upper 
3.4 cm served as control area 
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Figure III, representing the first evaluation, six days after the initial treatment, 
illustrates that the wound healing has evolved slightly in both parts. Though the lower, 
irradiated, part remains of inferior quality as regards to epithelialization and wound 
contraction. In the course of the reparative process, the influence of light exposures 
were registered. At 52 days after the first irradiation beneficial effects of LED 
treatment are clearly present (Figure IV).  
Figure IV: Surgical incision 52 days after initiating LED treatment. 
 
The irradiated area (2.6 cm) showed a more appropriate contracture than the control 
area (3.4 cm), characterized by less discoloration at scar level and a less hypertrophic 
scar. A similar trend was noticed at a third visual observation, 175 days after the initial 
treatment. At that moment no impairments at cutaneous sensitivity level were stated 
and the sensitivity showed no differences between left or right foot, nor between the 
two areas of the cicatrice. 
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DISCUSSION 
The results of this case study indicate that LED had a positive influence on wound 
healing in humans, as determined by visual observations. Many investigators, 
examining the effects of LPL on wound healing by means of a range of observation 
and treatment methods, reported accelerated and enhanced wound healing8-10, others 
described comparable outcomes using LED’s16,22,23,53. However, several LPL12-15 and 
LED21 studies were unable to repeat these results.  
The late but beneficial findings in this study seem to be to the credit of LED-therapy. 
Though several authors establish positive results in an earlier stage of the wound 
healing process8-10,20, one should question why the differences did not occur at the first 
evaluation, on day 6. An explanation can be found in the start of the treatment. Most 
investigators start LPL irradiation within 24 hours after traumatizing the skin8-10,14 so 
they influence a first cellular and vascular reaction with the production of chemical 
mediators of inflammation, resulting in an enhanced collagen production9, tremendous 
proliferation of capillaries and fibroblasts8 and stimulation of growth factors9. By the 
time the first treatment in this study took place, the traumatized tissue was in an 
overlapping stage between an almost finished inflammatory phase and a scarcely 
initiated re-epithelialization and wound contraction phase. At that moment an infiltrate 
of fibroblasts is present. So fibroblast proliferation, a possible mechanism of the 
biostimulative effect, had already occurred and could no longer be influenced. Growth 
factor production and collagen deposition have also decreased at that stage. 
Granulation tissue formation and fibroplasia in the contrary are initiating by that time. 
Those prolonged and slow processes with belated results, are of significant importance 
for the course of the final stage of wound healing and for the outlook of the future 
scar31.  
The experimental findings revealed that the sensitivity of the skin, according to the 
threshold detection method of Semmes and Weinstein, was normal, at all the 
investigated areas (treated and not treated). Bell et al54 claimed the 2.83 filament is a 
good and objective predictor of normal skin sensitivity. No other LPL nor LED 
studies investigating this quality of the skin were found. 
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CONCLUSION 
This study demonstrates that, although LED application at the applied energy density 
and irradiation frequency failed to stimulate the fibroblast proliferation, it does seem to 
have beneficial biostimulative effects on wound healing in human skin, confirmed by 
the favourable re-epithelialization and contracture.  
These results are discussed in the context of other experimental findings, but no 
reasonable explanation for this discrepancy could be found. The literature on wound 
healing after LED treatment in animal models or in humans is presently very limited 
and contradictory. The diversity in used radiation parameters and the absence of 
references on how the wounds were measured or evaluated, or what the end point was 
for ‘complete’ healing, cause difficulties in interpreting laboratory results. The in vitro 
investigations are better standardised, nevertheless these results show a number of 
conflicts. One can conclude that until today the controversial findings are characteristic 
for many results obtained with light photobiomodulation. 
However, the postponed favourable results in the case study confirm some facts of the 
discussion. Namely, the short period of incubation, 24 hours, in the in vitro part of the 
study can be responsible for the lack of enhanced fibroblast proliferation. It also 
confirms that other cell processes and morphologic changes possibly are responsible 
for biostimulative effects in vivo, other observation methods should be considered for 
future in vivo experiments.  
Despite these remarks, we believe that LED application on cutaneous wounds of 
human skin is useful with a single flash daily at the dose applied in this study for at 
least three days.  
Furthermore, future investigation is necessary to explain the mechanisms of LED 
biomodulation and to provide sufficient guidelines in the use of the most effective 
parameters for LED treatment.  Subsequently resolving the lack of scientific evidence 
and nullifying the controversial acknowledgements of the effect of LED can bring 
about a widespread acceptance for the use of LED in clinical settings. 
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ABSTRACT 
Background and Objective: As Light Emitting Diode (LED) devices are 
commercially introduced as an alternative for Low Level Laser (LLL) Therapy, the 
ability of LED in influencing wound healing processes at cellular level was examined. 
Study Design/Materials and Methods: Cultured fibroblasts were treated in a 
controlled, randomized manner, during three consecutive days, either with a infrared 
LLL or with an LED light source emitting several wavelengths (950 nm, 660 nm and 
570 nm) and respective power outputs. Treatment duration varied in relation to 
varying surface energy densities (radiant exposures).  
Results: Statistical analysis revealed a higher rate of proliferation (p<0.001) in all 
irradiated cultures in comparison with the controls. Green light yielded a significantly 
higher number of cells, than red (p<0.001) and infrared LED light (p<0.001) and than 
the cultures irradiated with the LLL (p<0.001); the red probe provided a higher 
increase (p<0.001) than the infrared LED probe and than the LLL source.  
Conclusion: LED and LLL irradiation resulted in an increased fibroblast proliferation 
in vitro. This study therefore postulates possible stimulatory effects on wound healing 
in vivo at the applied dosimetric parameters. 
 
Keywords: Biostimulation · Fibroblast proliferation · Light Emitting Diodes · Low 
Level Laser · Tetrazolium salt 
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INTRODUCTION 
Since the introduction of photobiostimulation into medicine, the effectiveness and 
applicability of a variety of light sources, in the treatment of a wide range of medical 
conditions [1-5]  has thoroughly been investigated, in vitro as well as in vivo. The results 
of several investigations are remarkably contradictory. This is at least in part a 
consequence of the wide range of indications, as well as the wide range of suitable 
parameters for irradiation and even the inability to measure the possible effects after 
irradiation with the necessary objectivity [4,5,7]. A lack of theoretical understanding 
can also be responsible for the existing controversies. In fact, theoretical understanding 
of the mechanisms is not necessary to establish effects, though it is necessary to 
simplify the evaluation and interpretation of the obtained results. As a consequence, 
the widespread acceptance of especially Low Level Laser (LLL) therapy, in the early 
seventies is faded nowadays and biostimulation by light is often viewed with scepticism 
[8]. According to Baxter [4,9], contemporary research and consumption in 
physiotherapy is in particular focused on the stimulation of wound healing. Tissue 
repair and healing of injured skin are complex processes that involve a dynamic series 
of events including coagulation, inflammation, granulation tissue formation, wound 
contraction and tissue remodelling [10]. This complexity aggravates research within this 
cardinal indication.  
Research in this domain mostly covers LLL studies, but the current commercial 
availability of other light sources, appeals research to investigate as well the effects of 
those alternative light sources, e.g. Light Emitting Diode (LED) apparatus. 
The scarcity of literature on LED is responsible for consultation of literature 
originating from LLL studies [11] but it may be wondered if this literature is 
representative for that purpose. As in the early days of LLL therapy, the stimulating 
effects upon biological objects were explained by its coherence [12,13], while the beam 
emitted by LED’s on the contrary produces incoherent light. Though the findings of 
some scientists [9,14,15,16,17] pose nowadays that the coherence of the light beam is 
not responsible for the effects of LLL therapy. Given that the cardinal difference 
between LED and LLL therapy, coherence, is not of remarkable importance in 
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providing biological response in cellular monolayers [5], one may consult literature 
from LLL studies to refer to in this LED studies. 
The purpose of this preliminary study is to examine the hypothesis that LED 
irradiation at specific output parameters can influence fibroblast proliferation. 
Therefore, irradiated fibroblasts cultures were compared with controls. The article 
reports the findings of this study in an attempt to promote further discussion and 
establish the use of LED.  
 
MATERIALS AND METHODS 
Cell isolation and culture procedures 
Fibroblasts were obtained from 8-days old chicken embryos. Isolation and 
disaggregation of the cells was performed with warm trypsin according the protocol 
described by Ian Freshney (1994) [18]. The primary explants were cultivated at 37°C in 
Hanks’ culture Medium supplemented with 10% Fetal Calf Serum, 1% Fungizone, 1% 
L-Glutamine and 0.5% Penicillin-Streptomycin. When cell growth from the explants 
reached confluence, cells were detached with trypsine and subcultured during 24 hours 
in 80-cm2 culture flasks (Nunc) in 12 ml of primary culture medium. After 72 hours 
the cells were removed from the culture flasks by trypsinization and counted by Bürker 
hemocytometry. For the experiment, cells from the third passage were plated in 96-well 
plates (Nunc) with a corresponding area of 0.33 cm2, they were subcultured at a 
density of 70.000 cell/cm2. Cultures were maintained in a humid atmosphere at 37° C 
during 24 hours. 
All supplies for cell culture were delivered by N.V. Life Technologies, Belgium, except 
for Fetal Calf Serum (Invitrogen Corporation, UK). 
 
Irradiation sources 
In this study two light sources, a Light Emitting Diode (LED) device and a Low Level 
Laser (LLL) device, were used in comparison to control cultures. 
The used LLL was an infrared, GaAlAs Laser (Unilaser 301P, MDB-Laser, Belgium) 
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with an area of 0.196 cm2, a wavelength of 830 nm, a power output ranging from 1-400 
mW and a frequency range from 0-1500 Hz.  
The Light Emitting Diode device (BIO-DIO preprototype, MDB-Laser, Belgium), 
consisted of three wavelengths emitted by separate probes. A first probe, emitting 
green light, had a wavelength of 570 nm (power-range, 10-0.2 mW), the probe in the 
red spectrum, had a wavelength of 660 nm (power-range, 80-15 mW) and the third 
probe had a wavelength of 950 nm (power-range, 160-80 mW) and emitted infrared 
light. The area of all three probes was 18 cm2 and their frequency was variable within 
the range of 0-1500 Hz.  
 
Exposure regime 
Prior to irradiation, the 96-well plates were microscopically verified, to guarantee that 
the cells were adherent, and to assure that there was no confluence, nor contamination. 
Following aspiration of 75% Hanks’ culture Medium irradiation started. The remaining 
25% (50 µl) medium avoided dehydration of the fibroblasts throughout irradiation. 
The 96-well plates were randomly assigned in the treated (LLL or green, red or infrared 
LED’s) or the control group. 
For the treatments in this study, the continuous mode was applied as well for the LLL 
as for the three LED-probes. The distance from light source to fibroblasts was 0.6 cm. 
LLL therapy consisted of 5 seconds irradiation at a power output of 40 mW resulting 
in a radiant exposure of 1 J/cm2. The infrared and the red beam delivered a radiant 
exposure of 0.53 J/cm2 and the green beam emitted 0.1 J/cm2, corresponding to 
exposure-times of respectively 1 minute, 2 minutes or 3 minutes and a respective 
power output of 160 mW, 80 mW or 10 mW. 
After these handlings, the remaining medium was removed and new Hanks’culture 
medium was added, followed by 24 hours of incubation. 
One irradiation (LLL or LED) was performed daily, during three consecutive days 
according to the aforementioned procedure. Control cultures underwent the same 
handling, but were sham-irradiated. 
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Determination of cell proliferation  
The number of cells within the 96-well plates, as a measure for repair [19], was 
quantified by a sensitive and reproducible colorimetric proliferation assay [20,21]. The 
colorimetric assay was performed at two different points of time to determine the 
duration of the effect of the used light sources. 
This assay exists of a replacement of Hanks’culture medium by fresh medium 
containing tetrazolium salt, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) 24 or 72 hours after the third irradiation, for MTT analysis as 
described by Mosmann (1983) [22]. Following a 4 hour incubation at 37°C, the MTT 
solution was substituted by lysing buffer, isopropyl alcohol. The plates were 
temporarily shaken to allow dissolution of the produced formazan crystals. After 30 
minutes of exposure to the lysing buffer, absorbance was measured. The absorbance at 
400 to 750 nm, which was proportional to fibroblast proliferation, was determined 
using an EL×800 counter (Universal Microplate Reader, Bio-Tek Instruments INC). 
The complete procedure from isolation to MTT assay was executed six times (Trial A, 
B, C, D, E and F) while it was impossible to irradiate all the investigated number of 
wells with the same LED apparatus on one day. All the trials included as much control 
as irradiated wells, but the number of control and irradiated wells in each trial varied, 
depending on the number of available cells after the second subculturing. A further 
consequence of the available number of cells is the number of probes examined per 
trial. Varying from 4 probes in trial A and F to 1 probe in trial B, C, D and E.  
Incubation period before proliferation analyses numbered 24 hours. To investigate if 
the stimulatory effect tends to occur immediately after irradiation or after a longer 
period of time, incubation in trial F lasted 72 hours.  
An overview of the followed procedures regarding incubation time before proliferation 
analysis, number of analysed wells for each trial and the number of probes examined 
per trial is given in table 1. As a consequence of the differences in procedures followed 
and because each trial started from a new cell line, the results of the five trials must be 
discussed separately.  
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Statistical analysis 
Depending on the amount of groups to be compared within each trial and depending 
on the p-value of the Kolmogorov-Smirnov test of normality, a T-test or one-way 
ANOVA was used for parametrical analyses and a Kruskal-Wallis or Mann-Whitney-U 
test was used for nonparametrical comparisons. Statistical significance for all tests was 
accepted at the 0.05 level. For this analysis Statistical Package for Social Sciences 10.0 
(SPSS 10.0) was used. 
 
RESULTS 
The results, presented in table 1, show that cell counts by means of MTT assay 
revealed a significant (p<0.001) increase in the number of cells in comparison to their 
respective sham-irradiated controls, for all the irradiated cultures of trial A, B, C, D, 
and E, except the irradiated groups in trial F.  
Moreover, the results of trial A showed that the effect of the green and red LED probe 
was significantly (p<0.001) higher than the effect of the LLL probe. With regard to the 
amount of proliferation the green probe yielded a significantly higher number of cells, 
than the red (p<0.001) and the infrared probe (p<0.001). Furthermore, the red probe 
provided a higher increase in cells (p<0.001) than the infrared probe. 
The infrared LED source and the LLL provided a significant (p<0.001) higher number 
of cells than the control cultures but no statistical significant difference was recorded 
between both light sources. 
The trials A, B, C, D, and E, regardless of the number of probes used in each trial, 
were analysed after 24 hours of incubation after the last irradiation. The incubation 
period of trial F lasted 72 hours. 
The means of trial F illustrated that the effect was opposite after such a long 
incubation. The control cultures had significantly (p<0.001) more fibroblasts than the 
irradiated cultures, with the exception of the LED-infrared group that showed a not 
significant increase of cells. Further analysis, revealed that the green probe yielded a 
significantly lower number of cells, than the red (p<0.001) and the infrared probe 
(p<0.001) and that the red probe provided a higher decrease (p<0.001) than the 
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infrared probe. Laser irradiation induced a significant decrease of fibroblasts in 
comparison to the infrared irradiated cultures (p<0.001) and the control cultures 
(p=0.001). LED irradiation with the green and the red probe revealed no statistical 
significant differences.  
 
Table 1: Fibroblast proliferation after LED and LLL irradiation 
 
Groups 
Absorbency 
(proportional to the 
number of fibroblasts)a 
Trial A   
     n=64 Control .595 ± .056 
     TP=24h Irradiated (LLL) .675 ± .050 * 
 Irradiated (LED-infrared) .676 ± .049 * 
 Irradiated (LED-red) .741 ± .059 * 
 Irradiated (LED-green) .775 ± .043 * 
Trial B   
     n=368 Control .810 ± .173 
     TP=24h Irradiated (LLL) .881 ± .176 * 
Trial C   
     n=368 Control .810 ± .173 
     TP=24h Irradiated (LED-infrared) .870 ± .178 * 
Trial D   
     n=192 Control .886 ± .084 
     TP=24h Irradiated (LED-red) .917 ± .066 * 
Trial E   
     n=192 Control .818 ± .075 
     TP=24h Irradiated (LED-green) .891 ± .068 * 
Trial F   
     n=64 Control .482 ± .049 
     TP=72h Irradiated (LLL) .454 ± .065 * 
 Irradiated (LED-infrared) .487 ± .044  
 Irradiated (LED-red) .446 ± .044 * 
 Irradiated (LED-green) .442 ± .035  * 
a Absorbency: proportional to the number of fibroblasts as determined 
by MTT analysis ± SD and significances (* p<0.001) in comparison to 
the control group 
n = number of analysed wells for each group within a trial 
TP = Time Pre-analysis, incubation time before proliferation analysis 
 
DISCUSSION 
Despite the failure of some studies [2,23] to demonstrate beneficial effects of laser and 
photodiode irradiation at relatively low intensities (<500mW) on fibroblast 
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proliferation, this study provides experimental support for a significant increased cell 
proliferation. Therefore these results confirm previous studies that yielded beneficial 
stimulating effect [1,15,24,25]. Remarkably though is the higher increase, noted after 
irradiation at lower wavelengths (570 nm). Van Breughel et al [26] observed a general 
decrease in absorption at longer wavelengths and concluded that several molecules in 
fibroblasts serve as photoacceptors, resulting in a range of absorption peaks (420, 445, 
470, 560, 630, 690 and 730 nm). The wavelength of the used ‘green’ LED probe is the 
closest to one of these peaks.  
Karu [5] also emphasises that the use of the appropriate wavelength, namely within the 
bandwidth of the absorption spectra of photoacceptor molecules, is an important 
factor to consider. 
In this particular context, penetration depth can almost be ignored as virtually all 
wavelengths in the visible and infrared spectrum will pass through a monolayer cell 
culture [12]. The irradiance (W/cm2) on the contrary, could have had an important 
influence on the outcome of this study. The higher increased proliferation by the lower 
wavelengths is possibly a result of the lower irradiance of these wavelengths. Lower 
irradiances are confirmed by other experiments to be more effective than higher 
irradiances [11,16,26].  
The used radiant exposures reached the tissue interaction threshold of 0.01 J/cm2 as 
described by Pöntinen [17], but in the scope of these results it also needs to be noticed 
that there is a substantial difference in radiant exposure between the LLL (1 J/cm2), 
the green LED probe (0.1 J/cm2) and the remaining LED probes (0.53 J/cm2). 
Consequently, the results of especially trial A and F must be interpreted with the 
necessary caution. It is possible that the determined distinction between the used light 
sources and the used probes is a result from the various radiant exposures applied 
during the treatments of the cultures. 
Notwithstanding the increased proliferation revealed with MTT analysis 24 hours after 
the last irradiation, this study was unable to demonstrate a stimulating effect when 
analysis was performed 72 hours after the last irradiation. Moreover, this longer 
incubation period even yielded an adverse effect. Although a weakening of the 
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photostimulating influence over time is acceptable, it can not explain a complete 
inversion. Especially in the knowledge that a considerable amount of authors still 
ascertain an effect after a longer incubation period [24,27]. In an attempt to illuminate 
this finding, one can suppose that the circadian response of the cells triggered by the 
LED and the LLL [12,28] forfeited after a prolonged period (72 hours) in the dark. 
The most obvious explanation is even though a decreased vitality and untimely cell 
death in the irradiated cell cultures as a result of reaching confluence at an earlier point 
of time than the control cultures. The cells of a confluent monolayer have the tendency 
to inhibit growth and finally die when they are not subcultured in time. No other 
reasonable explanations could be found for this discrepancy.  
 
Photo-modulated stimulation of wound healing is often viewed with scepticism. The 
real benefits of Light Emitting Diodes, if any, can only be established by histological 
and clinical investigations performed under well controlled protocols. Despite these 
remarks, this study suggests beneficial effects of LED and LLL irradiation at the 
cellular level, assuming potential beneficial clinical results. LED application on 
cutaneous wounds of human skin may be assumed useful at the applied dosimetric 
parameters, but future investigation is necessary to explain the mechanisms of LED 
biomodulation and to provide sufficient guidelines in the use of the most effective 
parameters for LED treatment.  Subsequently resolving the lack of scientific evidence 
and nullifying the controversial acknowledgements of the effect of LED can bring 
about a widespread acceptance for the use of LED in clinical settings.  
Persons in good health rarely require treatment for wound healing, as posed by Reddy 
et al [1,3] light has a possible optimal effect under conditions of impaired healing. 
Postponed wound healing is a time-consuming and often expensive complication. 
Thus, future prospects must remind to examine the therapeutic efficacy of LED on 
healing-resistant wounds. 
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ABSTRACT 
Background and Objective: The chronic metabolic disorder diabetes mellitus is an 
important cause of morbidity and mortality due to a series of common secondary 
metabolic complications, such as the development of severe, often slow healing skin 
lesions.  
In view of promoting the wound-healing process in diabetic patients, this preliminary 
in vitro study investigated the efficacy of green light emitting diode (LED) irradiation on 
fibroblast proliferation and viability under hyperglycemic circumstances. 
Materials and Methods: To achieve hyperglycemic circumstances, embryonic chicken 
fibroblasts were cultured in Hanks’ culture medium supplemented with 30 g/L 
glucose. LED irradiation was performed on 3 consecutive days with a probe emitting 
green light (570 nm) and a power output of 10 mW. Each treatment lasted 3 min, 
resulting in a radiation exposure of 0.1 J/cm2. 
Results: A Mann-Whitney test revealed a higher proliferation rate (p=0.001) in all 
irradiated cultures in comparison with the controls. 
Conclusion: According to these results, the effectiveness of green LED irradiation on 
fibroblasts in hyperglycemic circumstances is established. Future in vivo investigation 
would be worthwhile to investigate whether there are equivalent positive results in 
diabetic patients. 
 
Keywords: Light Emitting Diodes · Fibroblast proliferation · Diabetes 
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INTRODUCTION 
The chronic metabolic disorder diabetes mellitus is found worldwide. It exhibits wide 
geographic variation in incidence and prevalence; generally 1,1 % of the world 
population is affected and worldwide it is the twelfth leading cause of death.1 Those 
figures may be higher for urban regions as well as for industrialized countries. Due to 
multiple factors involving the aging process of the population and lifestyle changes 
(such as reduced physical activity, hypercaloric eating habits, and concomitant obesity), 
these figures may increase in the future.2-6 Therefore, diabetes mellitus could become 
the most common chronic disease in certain regions; as stated by Gale, it “targets the 
rich in poor countries and the poor in rich countries”.6 
The harmful disruption of the metabolic equilibrium in diabetes mellitus results in 
characteristic end-organ damage that occurs in various combinations and that follows 
an unpredictable clinical pathway. 
Accordingly, the major consequence of diabetes mellitus, in terms of morbidity, 
mortality, and economic burden, principally concerns macroangiopathies or 
arteriosclerosis and microangiopathies including nephropathy, neuropathy and 
retinopathy.7-10 
One of these devastating consequences, which often appears in time, is the 
development of various skin defects that are frequently resistant to healing and that 
tend to be more severe than similar lesions in nondiabetic individuals. Diabetes 
mellitus even increases the risk of infection by an increased susceptibility to bacteria 
and an impaired ability of the body to eliminate bacteria.11,12 
Skin problems are a severe complication in diabetic individuals and require a 
comprehensive and appropriate multidisciplinary approach to prevention and 
treatment.12 
Hyperglycemia is the key metabolic abnormality in diabetes mellitus that is believed to 
play the most prominent role in the development of diabetic complications. With the 
development of insulin treatment for type I diabetes and various oral hypoglycemic 
agents for type 2 diabetes, a reduction in the development of skin defects due to 
hyperglycemia should be noted.9,13-15 Nevertheless, once a lesion appears, simply 
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waiting for that lesion to heal spontaneously is often unsatisfactory. Wounds in 
diabetic patients often need special care in comparison to those persons in good 
health, who rarely require treatment for wound healing.16,17 Special care is directed, 
besides of course toward optimal diabetes regulation, toward patient education, 
maximum pressure relief, controlling infection, recovery of circulation in case of 
ischemia and different modalities of intensive wound treatment.18  
In the last few years, various therapies have been introduced, with varying success. An 
example of such a therapy is the photo-modulated stimulation of diabetic lesions. In 
vitro as well as in vivo, the effectiveness of especially low level lasers (LLL) has been 
subject of extensive investigation.19,20 Due to contradictory research results LLL-
photobiostimulation of injured skin is often viewed with scepticism.20-22 As the use of 
light in the domain of wound healing is less time-consuming, less expensive, less 
invasive than many of the other introduced treatment modalities, and practical to use 
however it seems worthwhile to investigate the value and benefits of a newly 
introduced and alternative light source, the light emitting diodes (LED’s). 
 
Preliminary research has proved that green LED with particular properties (an 
exposure time of 3 minutes, a power output of 10 mW and a radiant exposure of 0.1 
J/cm2) revealed positive stimulatory effects on fibroblast proliferation in vitro.23 These 
results may be of great importance to the diabetic patient because, as posed by Reddy et 
al., light has a possible beneficial effect in the case of impaired healing.16,17 
To obtain insight into the ability of LED to stimulate fibroblast proliferation under 
diabetic-specific conditions of impaired healing, the proliferation was assessed in 
irradiated and control cultures cultivated in medium with a high quantity of glucose.  
 
MATERIAL & METHODS 
Cell cultivation 
Primary fibroblast cultures were established by outgrowth from 8-day-old chicken 
embryos. After isolation and disaggregating as described by Freshney (1994)24, the cells 
were grown to confluence at 37°C in Hanks’ culture medium supplemented with 10% 
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fetal calf serum, 1% fungizone, 1% L-glutamine and 0.5% penicillin-streptomycin. 
Secondary cultures were initiated by trypsinization, followed by plating of the cells in 
80-cm2 culture flasks (Nunc) and cultivation during 72 h. The fibroblasts were 
disaggregated by trypsinization and counted by Bürker hemocytometry. Subsequently, 
2.31 x 104 fibroblasts (corresponding to a density of 7.0 x 104 cells/cm2) from the third 
passage were plated in the wells of 96-well tissue culture plates (Nunc). For 24 h, the 
cells were maintained in 200 µl supplemented Hanks’ culture medium and a humidified 
atmosphere at 37° C to allow them to attach to the bottom of the wells. 
 
Light source specifications and illumination procedure 
To control adherence of the cells and to assure that there was no confluence or 
contamination, the 96-well plates were microscopically examined before irradiation. 
Subsequently, the tissue culture plates were randomly assigned for use in the treated 
and control groups. Immediately before irradiation, 75% of the Hanks’ culture medium 
was aspirated. The remaining 25% (50 µl) medium avoided dehydration of the 
fibroblasts throughout irradiation.  
Irradiation was performed with a light emitting diode (LED) device. The LED device 
(BIO-DIO preprototype) emitted green light with a wavelength of 570 nm (power 
range, 0.2-10 mW). The area of the probe was 18 cm2 and its frequency was variable 
within the range of 0-1500 Hz.  
The investigation used the following illumination properties: the continuous mode, a 
distance of 0.6 cm from light source to fibroblasts, and a beam emission of 0.1 J/cm2 
radiant exposure. This procedure resulted in an exposure time of 3 min and a power 
output of 10 mW. Immediately after irradiation, the remaining medium was aspirated 
and the cells were restored in 200 µl Hanks’ culture medium containing 166.7 mM 
glucose (30 g/L) and incubated at 37° C.  
Irradiation and medium changes occurred at 1-day intervals, so one irradiation was 
implemented each 24 h for 3 days in a row, and from the first irradiation onwards, all 
medium renewals occurred with glucose-supplemented Hanks’ culture medium. 
Control cultures were handled in the same manner, but were sham-irradiated. 
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Proliferation assay 
Fibroblast survival and proliferation were determined by a sensitive and reproducible 
colorimetric assay; the assay, which detects merely living cells and the signal generated, 
bears a constant ratio to the degree of activation of the fibroblasts and the number of 
fibroblasts.25-27 It is a reliable method, as it considers all cells in a sample rather than 
only a small subsample.26 
Subsequent to an incubation period of 24 h, the 200 µl glucose-supplemented 
Hanks’culture medium was substituted by the same amount of Hanks’culture medium 
containing tetrazolium salt, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT).26,27 After 4 h of incubation at 37° C, the pale yellow MTT solution 
was replaced by the lysing buffer isopropyl alcohol, and the plates were shaken during 
30 min to dissolve the dark-blue formazan crystals and to produce a homogeneous 
solution. The optical density of the final solution was measured on an EL×800 counter 
(Universal Microplate Reader, Bio-Tek Instruments, Prongenbos, Belgium), using a test 
wavelength varying from 400 to 750 nm. 
The used light source was provided by MDB-Laser (Ekeren, Belgium) and all supplies 
for cell culture were delivered by N.V. Life Technologies (Merelbeke, Belgium), except 
for fetal calf serum supplied by Invitrogen Corporation (Paisley, UK). 
 
Data analysis 
On account of the p-value of the Kolmogorov-Smirnov test of normality (p=.034), a 
Mann-Whitney U test was performed for nonparametrical comparison of the results. 
Statistical significance for all tests was accepted at the 0.05 level. For this analysis the 
Statistical Package for the Social Sciences (SPSS 10.0; SPSS Inc., Chicago, IL) was used. 
 
RESULTS 
The MTT measurements from each of the 256 control wells and 256 irradiated wells 
and the subsequent nonparametrical analysis from the optical densities obtained, 
disclosed a significantly (p=0.001) higher rate of proliferation in hyperglycemic 
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circumstances after irradiation than in the same circumstances without irradiation (Fig. 
1). 
Fig. 1. Significantly (p=0.001) higher fibroblast proliferation in the 
irradiated group after green LED irradiation, as determined by MTT 
analysis (± SD). 
 
DISCUSSION  
The outcome of these in vitro experiments, based on the above-described light source 
properties and the illumination procedure described, clearly demonstrated the 
stimulatory potential of LED on fibroblast proliferation and the cell viability of 
fibroblasts cultured in hyperglycemic medium. Preliminary research has already 
demonstrated that, under these conditions (an exposure time of 3 min, a wavelength of 
570 nm, a power output of 10 mW, and a radiant exposure of 0.1 J/cm2), this 
procedure allowed the highest number of living cells. The nature of the light and the 
usual questions concerning coherence, wavelength, power output, and radiant 
exposures have been discussed previously.23 
Although these findings confirm the results previously found, one cannot ignore the 
important methodological difference between previous investigations and the current 
study, as the cells in this experiment were cultured in hyperglycemic medium.23,28-30 
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After a growth period with normal Hanks’ culture medium, a necessary step to ensure 
normal growth of these secondary subcultures and normal attachment to the bottom 
of the wells, the Hanks’ culture medium was supplemented with glucose.  
Several earlier studies have established that exposure to glucose concentrations (20-40 
mM) mimicing hyperglycemia of uncontrolled diabetes results in a restraint of human 
vascular endothelial cell proliferation.15,31-34 This restraint is more pronounced for 
higher glucose15 concentrations and is expressed especially after protracted exposure to 
high glucose levels.31 A similar restraint was found for cultured fibroblasts by 
Hehenberger et al.35,36 According to some authors, however, cultured fibroblasts 
conversely have been shown to maintain responsiveness to ambient high glucose.32,37,38 
As there are some ambiguities in literature regarding normal or inhibited growth of 
fibroblasts in medium supplemented with glucose,39 a pilot study was performed to 
determine the amount of glucose necessary to inhibit normal growth, after 72 h of 
culturing in 96-well plates at a density of 7.0×104 cells/cm2. This pilot study 
demonstrated that an amount of 166.7 mM glucose was necessary to cause a decrease 
of cell viability and to bring about a decline in fibroblast proliferation.  
This concentration resulted in a remarkable reduction of cell viability and a noteworthy 
decrease in the proliferation rate in comparison to control cultures grown in 5.5 mM 
glucose, although this concentration is too high to mimic severe diabetic 
hyperglycaemia (20-40 mM31-33). This high antiproliferative effect was necessary to 
investigate the effect of LED in distinct destructive conditions in order to obtain an 
incontrovertible result. 
In addition, it is possible that the present investigation needed a higher amount of 
glucose to result in a remarkable reduction of proliferation, as exposure to glucose was 
limited to 72 h, and as previous studies revealed that the antiproliferative effect of high 
glucose was more pronounced with prolonged exposure with a maximal inhibition 
attained by 7-14 days.15,31 
Moreover, with regard to the in vivo situation, it must be stated that in vitro and in vivo 
cell growth are too complex to compare. A key question is whether fibroblast 
senescence in tissue culture and in the intact organism are similar. Cristofalo et al.40 
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reported that this is not the case, as fibroblasts have a finite ability to divide and 
replicate; but apparently the pathway or the morphologic characteristics leading to the 
replicative senescence is not identical in vivo compared to in vitro.  
Furthermore extrinsic aging, related to environmental damage, which in diabetic 
patients, is mainly due to a chronic exposure to high levels of glucose during life, is 
unachievable in vitro.  
Unless a number of questions regarding the mechanism according to which LED 
stimulates fibroblast proliferation in this particular condition remain unanswered, the 
results ascertain the potential effects of LED on fibroblast proliferation and viability.  
 
CONCLUSION 
The current results should be interpreted with caution. However, these results 
demonstrate the effectiveness of green LED irradiation at the above-described light 
source properties and the illumination procedure described on cells in hyperglycemic 
circumstances.  
The findings of the present study, using an experimental in vitro model, indicate that the 
use of LED irradiation to promote wound healing in diabetic patients may have 
promising future results. As the present study establishes the possibility of using LED 
irradiation in experimental in vitro situations, it would be a worthwhile extension to 
perform in vivo investigations to determine whether these in vitro observations were 
relevant to the physiological situation and to determine the effect of these LED 
properties on human tissue response.  
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ABSTRACT 
The introduction of light emitting diode (LED) devices as a novel treatment for pain 
relief in place of low-level laser warrants fundamental research on the effect of LED 
devices on one of the potential explanatory mechanisms: peripheral neurophysiology in 
vivo.  
A randomised controlled study was conducted by measuring antidromic nerve 
conduction on the peripheral sural nerve of healthy subjects (n=64). One baseline 
measurement and five post-irradiation recordings (2 min interval each) were performed 
of the nerve conduction velocity (NCV) and negative peak latency (NPL). 
Interventional set-up was identical for all subjects, but the experimental group (=32) 
received an irradiation (2 min at a continuous power output of 160 mW, resulting in a 
radiant exposure of 1.07 J/cm2) with an infrared LED device (BIO-DIO preprototype; 
MDB-Laser, Belgium), while the placebo group was treated by sham irradiation. 
Statistical analysis (general regression model for repeated measures) of NCV and NPL 
difference scores, revealed a significant interactive effect for both NCV (p=0.003) and 
NPL (p=0.006). Further post hoc LSD analysis showed a time-related statistical 
significant decreased NCV and an increased NPL in the experimental group and a 
statistical significant difference between placebo and experimental group at various 
points of time.  
Based on these results, it can be concluded that LED irradiation, applied to intact skin 
at the described irradiation parameters, produces an immediate and localized effect 
upon conduction characteristics in underlying nerves. Therefore, the outcome of this in 
vivo experiment yields a potential explanation for pain relief induced by LED. 
 
Keywords: Light Emitting Diodes · Sural nerve · Conduction velocity · Negative 
peak latency · Analgesic effect 
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INTRODUCTION 
Since the introduction of photobiostimulation into medicine, the light sources used 
have advanced technologically and varied in characteristics over the years. 
Advancement and variation of the sources implicate a concomitant necessity to revise 
research results in the respective domains of application. Research and clinical 
applications, in the past particularly focused on the effectiveness of low-level lasers, 
have shifted now to novel treatment units, such as light emitting diode (LED) devices.  
The efficacy and applicability of LED irradiation within the field of wound healing has 
already partially been substantiated, in vitro [1,2] as well as in vivo [3-6]. However, LED 
is not only promoted for its beneficial effects on the wound-healing process, it is also 
suggested to be potentially effective in the treatment of pain of various aetiology, 
although this claim has not yet been investigated thoroughly, either experimentally or 
clinically.  The putative analgesic effects of LED remain to be further explored. 
As the basic vehicle of pain is the neuronal system [7], measuring the 
neurophysiological effect of LED treatment would be an appropriate experimental 
approach to investigate the efficacy of LED on pain inhibition. Nerve conduction 
studies have become a technique for investigating the neurophysiologic effects of light 
therapy [8-9]. 
Review of literature regarding standard nerve conduction studies revealed that previous 
human studies on the influence of various light sources on peripheral nerves have 
utilized different methods, which hampers a comprehensive comparison. In general, 
this research was performed on  the superficial radial nerve [10-13], described by Shin J 
Oh [14] as an uncommon nerve conduction technique, or on the mixed median nerve 
[8,9,13,15-17]. Following the method of Cambier et al. [18] the authors of this study 
decided to investigate the effect of the light source used on the conduction 
characteristics of the sural nerve. By investigating this solely sensory nerve, interaction 
of motor nerve fibres (motor response can easily be provoked by antidromic nerve 
stimulation [19]) can be avoided and given the superficial nature of the nerve, it should 
be sufficiently amenable to the effects of percutaneous LED irradiation. 
Chapter 4 
 78
A second major difference between the trials, and therefore also hindering an 
appropriate comparison between the results, is the wide range of used light sources: 
HeNe lasers [12,13,16] and GaAlAs lasers [8-10,17,18] or a monochromatic infrared 
multisource treatment unit [15]. 
With respect to the potential importance of LED irradiation for the treatment of pain, 
the current investigation was designed to assess the putative neurophysiological effects 
of LED on the sensory nerve conduction of the human superficial peripheral sural 
nerve and to establish a time course of the supposed phenomenon.  
The experimental hypothesis postulates that LED generates an immediate decrease in 
conduction velocity and increase in negative peak latency. In addition, it can be 
postulated that this effect is most prominent immediately after the irradiation and will 
weaken as time progresses. 
 
STUDY DESIGN 
The study was approved by the Ethical Committee of the Ghent University Hospital. 
After explanation of the experimental procedure, a written informed consent was 
obtained from each subject. 
 
Subjects 
After screening, based on a brief medical history, excluding subjects with 
contraindications to LED irradiation (such as light hypersensitivity, fluctuating blood 
pressure, insufficient blood circulation, fever, inflammation of the skin) or conditions 
that might affect sensory nerve conduction (such as diabetes, peripheral neuropathy, 
radicular syndrome, peripheral nerve damage, neuromuscular disorders or peripheral 
edema), eligible subjects were enrolled. Sixty-four healthy volunteers, 24 males and 40 
females (mean age 26±6 years, range 18-42 years), participated in this study. The body 
mass index (BMI) of each subject varied within the normal range (=18.5-24.9) [20] 
(mean BMI  21.6±1.7, range 18.6-24.9). Subjects were randomly allocated to a placebo 
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or an experimental group. Each group of 32 subjects was composed of 12 males and 
20 females.  
 
Experimental Procedure and Data Acquisition 
In order to be able to quantify the negative peak latency (NPL) (measured from the 
start of the stimulus artefact to the peak of the negative portion of the nerve action 
potential) and nerve conduction velocity (NCV) of the sural nerve, a rigid protocol was 
followed.  
With respect to the known relationship between nerve conduction characteristics and 
temperature, the ambient temperature was kept constant (23ºC-26ºC room 
temperature) during the investigation. In view of this temperature issue, the 
standardized protocol started with 10 min of accommodation, during which the 
subjects rested in prone position on a treatment table.  
Immediately before this adjustment period, the skin over the dorsolateral aspect of the 
left calf and foot was cleaned with alcohol to remove surface lipids. This preparation of 
the treatment area was followed by the placement of the electrodes (TECA 
Accessories; Oxford Instruments Medical Systems Division, Old Woking, UK) as 
described by Delisa et al. [21]. 
The two-posted (2 cm separation, anode distal) surface caption electrode was placed 
distal and posterior of the lateral malleolus, on the skin covering the sural nerve. The 
fixation of the earth electrode (Medelec; Oxford Instruments Medical Systems 
Division, Old Woking, UK) occurred 12 cm above the caption electrode, according to 
the description of Delisa et al. [21]. A standard bipolar stimulator was used at 14 cm 
above the caption electrode to map the ideal stimulation point. To level off 
intraindividual variations in the amount of sensory response, attributable to the 
successive placement of the bipolar stimulator in course of the investigation, a two-
posted (2 cm separation, cathode distal) bar stimulating electrode was attached at the 
point where the maximal response was obtained.  
This placement of the electrodes allows antidromic stimulation of the sural nerve. 
Electrophysiological stimulation and recordings were obtained with a Medelec 
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Sapphire Premiere (Vickers Medical, Old Woking, UK), providing a monophasic pulse 
of 0.1 ms. A supramaximal stimulus intensity, with a nominal voltage of 72-295, was 
used to produce each evoked sensory response.  
Baseline measurements of NPL and NCV were immediately followed by treatment of 
the subjects, according the protocol detailed below. Recordings were subsequently 
repeated at 2-min intervals over an 8-min period, resulting in five recordings (one 
immediately after the completion of the treatment and one at 2, 4, 6, and 8 min after 
irradiation). Skin temperature was recorded concomitantly throughout the procedure: 
at the time of baseline measurement, immediately after LED irradiation at the time of 
the first recording and consequently at 2-min intervals, together with the four final 
electrophysiological recordings. For this, a surface digital C9001 thermometer 
(Comark, UK), sensitive to temperature changes of 0.1°C, was used at the same point 
of LED administration, namely at 7 cm above the caption electrode. The procedure 
was identical for both conditions, but subjects in the placebo group received a sham 
LED irradiation.  
 
Light Characteristics and Irradiation Procedure 
Irradiation was administrated with a light emitting diode device (BIO-DIO 
preprototype; MDB-Laser, Belgium). The probe used emitted infrared light with a 
wavelength of 950 nm (power range, 80-160 mW). The area of  the probe was 18 cm2 
and the frequency was variable within the range of 0-1500 Hz. 
Preceding baseline measurement, the treatment point was marked on the skin overlying 
the course of the sural nerve at 7 cm above the capture electrode, i.e. the exact mid-
point between the stimulation and capture electrode. The LED probe was held in 
contact with the skin, perpendicular to the skin surface during the complete irradiation 
procedure. LED treatment consisted for all subjects of the experimental group out of 2 
minutes lasting irradiation. The LED was set to deliver a continuous energy density of 
1.07 J/cm2, at a power output of 160 mW. These parameters were selected, as they are 
appropriate for the treatment of pain in a clinical setting. First of all, because the 
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duration of the treatment is clinically feasible and secondly because the parameters are 
within the scope of previously described light source characteristics [1-3,6,9,15]. 
 
Statistics 
Although superficial skin temperature did not change significantly in course of the 
investigation, the influence of the measured skin temperature on NPL and NCV was 
taken into account by using a correction factor of, respectively, 0.2 ms/°C and 1.47 
m/s °C. All corrections were calculated towards a reference skin temperature of 32°C. 
Difference scores, i.e. the variation between baseline measurements and each post-
irradiation recording, were used as the basis for statistical analysis. A General 
Regression Model for repeated measures with one within-subjects factor (time: 0 
min=immediately after irradiation, 2, 4, 6 and 8 min following LED irradiation) and 
one between-subjects factor (group: placebo or LED irradiated) was performed, 
followed by appropriate pairwise comparisons (post hoc LSD or post hoc Least 
Significant Difference), to determine whether any differences between baseline 
measurements and post-irradiation recordings were statistically significant. 
The Statistical package for social sciences (SPSS 11.0) was used for analysis and 
statistical significance for all tests was accepted at the 0.05 level. 
 
RESULTS 
Figure 1 shows NCV mean difference scores of the placebo and the LED irradiated 
group plotted against time in minutes. The values of the irradiated subjects decrease 
directly after the irradiation and reach a first low point 2 min after finishing LED 
treatment. This decrease is followed by a marginal increase at 4 and 6 min and again an 
important decrease at 8 min. Statistical analysis (general regression model for repeated 
measures) of these data indicated a significant interactive effect (P=0.003).  
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Fig. 1 Mean difference scores (m/s; variation between baseline measurements and 
post-treatment recordings) of the nerve conduction velocity plotted against time 
(minutes) (means±SD; n=32) 
 
Post hoc LSD further showed significant differences between baseline measurements 
and all post-treatment recordings (Table 1). Mutual comparison of the values from the 
post-treatment recordings did not reveal any significant difference. In addition, there 
was no significant difference determined in the placebo group in course of time. 
Table 1 Summary of the influence of LED irradiation on nerve conduction velocity 
Minutes Placeboa 
Time-Related 
Significance b
LEDa 
Time-Related 
Significance b 
Group 
Significance c 
0 0.171±0.353 0.329 -0.752±1.348 0.002* <0.001* 
2 -0.008±0.357 0.969 -0.915±1.520 0.004* 0.002* 
4 0.111±0.377 0.647 -0.908±1.898 0.021* 0.004* 
6 0.055±0.397 0.770 -0.809±1.301 0.002* <0.001* 
8 0.021±0.386 0.932 -1.146±1.881 0.003* 0.001* 
a Mean difference scores and standard deviations of the recorded nerve conduction velocity of the 
placebo and the LED irradiated group 
b P-values of the pairwise comparison (post hoc LSD) between baseline measurements and all post-
treatment recordings (baseline=preceding irradiation, 0 min=immediately after irradiation, 2, 4, 6 and 
8 min following LED irradiation) of the placebo and the LED irradiated group 
c P-values of the pairwise comparison (post hoc LSD) between placebo and irradiated subjects, for all 
post-treatment recordings (0 min=immediately after irradiation, 2, 4, 6 and 8 min following LED 
irradiation) 
* Significant P-values (P<0.05) 
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A similar representation was used for the results of the NPL. Figure 2 reproduces NPL 
plotted against time in minutes, revealing for the irradiated group an increased latency 
with two important peaks, one at 4 min and one at 8 min.  
 
Fig. 2 Mean difference scores (variation between baseline measurements and post-
treatment recordings) of the negative peak latency plotted against time (minutes) 
(means±SD; n=32) 
 
Statistical analysis of the mean difference scores again indicated a significant interactive 
effect (P=0.006). Further post hoc LSD analysis of the data, presented in Table 2, 
showed significant differences between baseline measurements and all post-treatment 
recordings of the experimental group. The mean difference score of the first post-
treatment recording of this same group (LED irradiated) differed significantly with the 
recording 4 min (P=0.003), 6 min (P=0.018) and 8 min (P<0.001) after LED 
irradiation. As well as the recording 2 min after irradiation which differed significantly 
(P=0.013) with the 8 min post-treatment recording. As observed for the NCV, the 
NPL of the placebo group did not reveal any significant difference in time course. 
At the time of the final recording, the NCV and NPL mean difference scores of the 
irradiated group did not return to their respective baseline values.  
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Furthermore, post hoc LSD analysis, also presented in Tables 1 and 2 (group 
significance), revealed statistical differences between the experimental and the placebo 
group for NCV as well as for NPL. NCV and NPL were statistical significant between 
both groups at all points of time, except from the NPL recording immediately after 
finishing irradiation. 
 
DISCUSSION 
Notwithstanding the above-mentioned difficulties in comparing results between 
different trials, on nerve conduction, we attempt to discuss the current findings in view 
of the results of the previous studies. 
This investigation revealed that percutaneous LED irradiation at feasible and current 
clinical parameters, generates measurable and significant changes in human sural nerve 
antidromic conduction latency and velocity. These results thus support previous 
findings of light-mediated nerve conduction latency shifts in vivo [8,10,12,18], 
although there are several important issues to be discussed. 
Table 2 Summary of the influence of LED irradiation on negative peak latency 
Minutes Placeboa 
Time-Related 
Significance b 
LEDa 
Time-Related 
Significance b 
Group 
Significance c
0 0.004 ±0.053 0.755 0.029±0.080 0.0.19* 0.145 
2 -0.002 ±0.046 0.856 0.044±0.100 0.002* 0.021* 
4 0.001 ±0.056 0.925 0.058±0.090 <0.001* 0.004* 
6 0.015 ±0.054 0.216 0.052±0.079 <0.001* 0.034* 
8 0.014 ±0.052 0.264 0.064±0.088 <0.001* 0.007* 
a Mean difference scores and standard deviations of the recorded negative peak latency of the placebo 
and the LED irradiated group 
b P-values of the pairwise comparison (post hoc LSD) between baseline measurements and all post-
treatment recordings (baseline=preceding irradiation, 0 min=immediately after irradiation, 2, 4, 6 and 
8 min following LED irradiation) of the placebo and the LED irradiated group 
c P-values of the pairwise comparison (post hoc LSD) between placebo and irradiated subjects, for all 
post-treatment recordings (0 min=immediately after irradiation, 2, 4, 6 and 8 min following LED 
irradiation) 
* Significant P-values (P<0.05) 
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A first comment deals with the progress of the NCV and NPL in function of time. As 
postulated, the NCV decreases significantly immediately after irradiation, 
corresponding with a significant increased NPL. However, this effect does not weaken 
as time progresses, both variables remain significant throughout the 8 min during 
observation period. 
Cambier et al. [18] noted a similar significant effect of GaAlAs laser irradiation on the 
conduction characteristics until 15 minutes post-treatment, as did Walsh et al. [10], 
although this slight increase in NPL was not significant at any moment. Two other 
studies [8,22] with a GaAlAs laser even registered comparable effects over a period of 
55 [8] and 60 min [22] post-irradiation, respectively. Given the results of these previous 
studies, post-treatment conduction measurements should be extended in time. At 
present, for all studies, it remains unclear at what point of time the effect extinguishes, 
although the interval of time during which LED treatment remains effective is 
clinically important when treating pain. 
Noble et al. [15] also noticed relatively long-lasting neurophysiological effects (at least 
45 min) mediated by a monochromatic multisource infrared diode device, although it 
needs to be mentioned that this study, performed with a comparable light source as the 
current investigation, revealed a significant decrease of the NPL. These inverse results 
between the study of Noble et al. [15] and the current investigation could be attributed 
to the concomitant increase of the skin temperature [15]. As it has been well 
recognised that a variation in tissue temperature causes a corresponding alteration in 
nerve conduction velocities and peak latencies [9,15,23-27], the temperature changes 
may indeed provide an explanation for the observed findings. In an attempt to analyse 
the influence of a direct photobiological effect on sural nerve conduction 
characteristics, rather than working out the effects based upon thermal mechanisms, 
the present study corrected the skin temperature towards a reference temperature of 
32°C. This correction was performed notwithstanding the fact that the superficial skin 
temperature did not change significantly before and after LED irradiation, as well as 
despite the fact that influencing nerve temperature takes place long after affecting skin 
temperature [23], and thus being (almost) impossible after 2 min of irradiation, 
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followed by 8 min of registration. Introduction of the correction factor implies likewise 
that eventual influence on nerve conduction by cooling of the limb due to inactivity, as 
described by Greathouse et al. [11], can be excluded. 
These facts suggest that temperature changes did not contribute to the demonstrated 
effects of LED on nerve conduction. Nevertheless the underlying mechanism of the 
observed effects remains indistinct. 
A following remark regarding the fluctuation of NCV and NPL in function of time 
considers the fact that both the NCV and the NPL do not change in a constant way up 
to eight minutes after LED irradiation (Figs 1, 2). The decrease in NCV and the 
increase in NPL display a small though not significant inversion of the effect at 4 and 
(NCV) or 6 (NPL) min. This is probably attributable to the fact that some degree of 
fluctuation is to be expected when measuring NCV and NPL, besides there is a similar 
variation in the placebo groups. 
Although investigating dose dependency was not intended, an additional remark 
considers the fact that the use of optimal irradiation parameters is essential to obtain 
the observed neurophysiological effect. Nevertheless, it is impossible to determine 
ideal light source characteristics for effective treatment, as the range of used 
wavelengths (632-950 nm), radiant exposures (1.07-9.6 J/cm2) and even frequency 
(pulsed or continuous) are not sufficiently similar between the different studies. It can 
only be concluded that a pulsing light source [9,10,28] does not provide the postulated 
results. Radiant exposure, exposure time, power range and wavelength are not yet 
established, but based on this study and previously described assays, it can be 
speculated that the ranges of these parameters are quite large. 
In comparison with other studies where the number of subjects is 10 or less [8-
11,15,16,22,29] (with the exception of the studies from Cambier et al. [18] and Snyder-
Mackler et al. [12], who respectively tested 15 and 24 subjects), a relatively large number 
of subjects (n=32) was investigated in each group. In spite of the large investigated 
population, it should be noted that the magnitude of the described changes in NCV 
and NPL can simply be replicated by lowering the temperature of the extremity, as the 
observed changes are within the expected physiological ranges, making the clinical 
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significance of the change questionable. (This fact does not implement that the 
decrease and the significant changes were temperature mediated.)  
A key question, and meanwhile the initial impetus for future investigation, is whether 
the measured effects can be extrapolated to the actual nociceptive afferents, namely the 
myelinated Aδ-fibres(12-30 m/s [14]) and unmyelinated C-fibres (0.5-2 m/s [14]), 
respectively, conducting acute and chronic pain. The functional testing of these 
nociceptive pathways has recently been extensively evaluated. The currently accepted 
neurophysiological method of assessing nociceptive pathways relies on laser-evoked 
potentials (LEPs) [30], as they selectively activate Aδ-fibres and C-fibres [31]. 
As up till now, LEP is not available in this or any surrounding research centre, the 
investigators of this study had to perform a standard nerve conduction study (assessing 
the large myelinated Aβ afferents). Therefore, the current and previous beneficial 
results of low level light therapy on conduction characteristics of nerves in vivo should 
initiate measurements of clinical effectiveness, first of all in laboratory settings and 
afterward at a clinical level. 
 
CONCLUSION 
Despite these remarks and the limited knowledge regarding the underlying mechanism, 
the present findings enable the following conclusions to be drawn: LED irradiation at 
clinical applied energy densities produces an immediate and localized effect upon 
conduction characteristics in underlying nerves. More specifically, it is proven that 
LED treatment lowers the NCV and augments the NPL, resulting in a reduced 
number of impulses per unit of time. Therefore, the outcome of this in vivo experiment 
assumes that LED possibly induces pain relief. 
In order to encourage a widespread acceptance for the use of this non-invasive pain-
reducing modality in clinical settings, prospective research should establish the precise 
relationship between LED and pain relief, as well as determine the ideal irradiation 
parameters and verify which painful conditions can be treated with this treatment unit.  
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ABSTRACT 
Objective: The present pilot study investigated the analgesic efficacy of light emitting 
diode (LED). In view of a standardised and controlled pain reduction study design this 
in vivo trial was conducted on experimentally induced delayed-onset muscle soreness 
(DOMS). 
Design: Thirty-two eligible human volunteers were randomly assigned to either an 
experimental (n=16) or placebo group (n=16). Immediately following the induction of 
muscle soreness, perceived pain was measured by means of a visual analog scale (VAS), 
followed by a more objective mechanical pain threshold (MPT) measurement and 
finally an eccentric/concentric isokinetic peak torque (IPT) assessment. The 
experimental group was treated with infrared LED at one of both arms, the other arm 
served as control. Irradiation lasted 6 min at a continuous power output of 160 mW, 
resulting in an energy density of 3.2 J/cm2. The subjects of the placebo group received 
sham irradiation at both sides. In post-treatment, a second daily assessment of MPT 
and VAS  took place. The treatment and assessment procedure (MPT, VAS and IPT) 
was performed during 4 consecutive days. 
Results: Statistical analysis (a general linear model followed by post hoc least 
significant difference) revealed no apparent significant analgesic effects of LED at the 
above-described light parameters and treatment procedure for none of the three 
outcome measures. However, as the means of all VAS and MPT variables disclose a 
general analgesic effect of LED irradiation in favour of the experimental group, 
precaution should be taken in view of any clinical decision on LED.  
Conclusion: Future research should therefore focus on the investigation of the 
mechanisms of LED action and on the exploration of the analgesic effects of LED in a 
larger randomised clinical trial and eventually in more clinical settings. 
 
Keywords: Light Emitting Diode · Infrared · Analgesic effect · Delayed-onset 
muscle soreness · Musculus biceps brachii 
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INTRODUCTION 
The analgesic efficacy of light emitting diode (LED) irradiation is recently being 
investigated by means of a nerve conduction study on the superficial peripheral sural 
nerve [1]. It was demonstrated that LED irradiation at clinical applied densities 
produces an immediate and localized effect upon conduction characteristics in 
underlying nerves. More specific, LED induces a decreased number of sensory 
impulses per unit of time, thus possibly inducing pain relief [1]. 
Given the established influence of this treatment modality on the nerve conduction 
velocity and thereby its potential analgesic ability, the current investigation was 
designed.  
Studies investigating the efficacy of a therapeutic modality on pain often experience 
difficulties regarding standardisation of the population, as analysis or comparison of 
pain with different aetiologies is almost impossible. Therefore we opted to measure the 
analgesic effects of LED in a laboratory setting on a sample with experimentally 
induced delayed-onset of muscle soreness (DOMS).   
Muscle soreness usually occurs at the musculotendinous junction 8-24 h after the 
induction exercise, and then spreads throughout the muscle [2-4]. The correlates of 
DOMS reach peak intensity at 24-48 h with symptoms disappearing around days 5-10 
[2, 3, 5-10]. The cardinal signs, characterising DOMS, are reduced muscle force, 
decreased range of motion and, in particular, muscle pain which is more pronounced 
during movement and palpation [8, 11]. Despite the large volume of research that has 
been undertaken to identify the underlying pathophysiology of DOMS, the precise 
mechanism is not yet universally accepted. Several theories, such as the torn-tissue 
theory, the connective tissue damage theory, the muscle spasm theory, and the 
inflammation theory still remain viable, though the current opinion states that DOMS 
arises from a sequence of events in which several theories occupy an important place 
[2, 6, 12, 13]. 
DOMS has been used as a representative model of musculoskeletal pain and stiffness 
in a number of studies [4, 7, 11, 14, 15], as it has a number of advantages: it can be 
induced in a relatively easy and standardised manner in a group of healthy subjects, the 
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time-course is relatively predictable, and the symptoms have the same aetiology and are 
of transitory nature [14, 16]. Nevertheless, it should be emphasised that the use of this 
particular experimental model to test the effectiveness of LED does not mean that this 
treatment modality is necessarily advocated for the treatment of DOMS, but merely 
that it may be helpful in documenting the efficacy of LED in a clinical model of 
musculoskeletal pain and stiffness. In addition, studies based on the induction of 
DOMS under carefully controlled laboratory conditions can not replace research 
involving actual patients, but offer the opportunity to assess the effectiveness of 
particular therapeutic interventions and might help to define additional clinical research 
[14].  
The experimental hypothesis of the current study postulates that infrared LED reduces 
pain and muscle sensitivity associated with DOMS.  
 
MATERIALS AND METHODS 
The study was approved by the ethical committee of the Ghent University Hospital. 
After providing information regarding the study design and possible consequences 
related to participation at the study, written informed consent was obtained from each 
subject. 
 
Subjects 
Healthy human volunteers were recruited from the university population. Individuals 
with any upper limb pathology, neurological deficit, and recent injury to either upper 
extremity or undiagnosed pain were excluded. Other exclusion criteria were 
contraindications to LED irradiation (such as light hypersensitivity, fluctuating blood 
pressure, insufficient blood circulation, fever, and inflammation of the skin) or 
conditions in which physical exertion is contraindicated (such as cardiovascular deficits, 
hypertension, and respiratory problems). 
Thirty-two eligible subjects (16 males and 16 females), aged 19-35 years (mean age 
23±4 years), were enrolled. All subjects were randomly assigned, using a random table 
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of numbers, to the experimental or placebo group. Each group of 16 subjects 
consisted, by stratification, of equal numbers of men and women. Age, height and 
weight did not differ significantly between the three groups. 
All subjects were physically active; however none performed on a regular basis any type 
of upper body weight-training. Subjects were requested to refrain from any form of 
strenuous physical activity and they were asked to avoid any form of medication, 
including anti-inflammatory agents, as well as alcohol for 2 days before testing and for 
the duration of the study.  
 
Overview of experimental design 
The study lasted 4 consecutive days. On day 1, isokinetic exercise was performed to 
induce pain related to DOMS. Immediately following induction exercise, an initial 
assessment of the outcome measures (visual analog scale or VAS, mechanical pain 
threshold or MPT, and isokinetic peak torque or IPT) occurred. Subsequently the 
subjects were treated, under blinded conditions, according to the randomised group 
allocation. In post-treatment, the MPT was re-recorded and perceived pain was 
reassessed with a VAS. Contrary to these outcome measures, the muscle strength was 
only measured in pre-treatment, at the one hand, because short-term effects of LED 
on muscle strength were not postulated and, on the other hand, because post-
treatment muscle strength can be influenced by too many different physiological 
factors related to the pre-treatment measurement. On the succeeding days (day 2, 3, 
and 4), the treatment and assessment procedure was similar, with approximately 24 h 
separating each treatment.  
In both of the groups the two arms of the participants were included in the study. In 
the experimental group an equal number of dominant and non-dominant arms were 
treated. The non-treated arm served as control arm. In the placebo group, also an equal 
number of dominant and non-dominant arms were considered as treated arm, and the 
other arm was classified in the non-treated group. The procedure was identical for 
both conditions, but the subjects in the placebo group received sham LED irradiation 
on both arms.  
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Specific aspects of the experimental design and procedures are detailed below. 
 
Pain induction  
Muscle soreness was induced in a standardised fashion via a daily calibrated computer-
operated Biodex isokinetic dynamometer (Biodex Medical Systems, Inc., Shirley, NY, 
USA). Induction occurred separately and in random order in the elbow flexors of both 
arms. Therefore, the subjects were seated as described by the users’ manual of Biodex. 
Prior to induction of DOMS, the subjects were allowed an initial familiarization session 
to become comfortable performing maximum voluntary contractions at the required 
angular velocities. This was immediately followed by determination of the maximum 
eccentric and concentric peak torque at an angular velocity of 60°/s and 120°/s. 
Subsequently, four sessions of eccentric/concentric work were performed with each 
arm. The first two sessions consisted of elbow flexion at an angular velocity of 60°/s, 
first of all, along an arch of 120°, from full extension (designated as 0°) through 120° 
and, second of all, elbow flexion over a range of 60°, from 30° to 90° of flexion (mid-
range); followed by two sessions at an angular velocity of 120°/s, again the first time 
along an arch of 120° and followed by the mid-range performance. The subjects were 
asked to accomplish maximum voluntary contractions during all the sessions. Each 
session was performed until exhaustion, which was defined as the point when the 
subject lost 70% of the initial eccentric and concentric peak torque. There was a 1-
minute rest between each session. This procedure was based on a pilot study and 
previously described induction protocols [17-21]. 
 
Outcome measures 
Outcome measures of subjective pain measurements, MPT, and muscle strength were 
measured in this order on days 1-4. Subjective pain measurements and MPT occurred 
immediately prior to and following irradiation, whereas muscle strength measurements 
only took place before LED treatment. 
Measurement of subjective pain Perceived muscle soreness was measured 
subjectively by means of a 100-mm VAS. A series of scales were completed separately 
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for each arm: pain at rest, followed by pain perception associated with full extension of 
the arms and finally with maximal flexion of the arms. The subjects were not allowed 
to compare one VAS result with another.  
This assessment tool, commonly used in measuring experimentally induced pain [22, 
23], has been found to be a reliable and valid method [24-26].  
 
MPT / Tenderness MPT, used as a more objective correlate of muscle tenderness, 
has been demonstrated to be a reliable method to measure experimental induced 
muscle soreness [27]. This outcome measure was assessed by using a handheld 
pressure algometer with a 1.2-cm diameter head (Microfet 2; Hoggan Health Industries, 
South Jordan, USA). On day 1, three points were marked at 4-cm intervals [8] along a 
line from the radial insertion of the musculus biceps brachii at the elbow to the 
intertubercular groove of the humerus, thus resulting in three measure points, one at 
the musculotendinous junction (4 cm) and two at the muscle belly (8 cm and 12 cm). A 
pressure of 4N/s was delivered. The subjects were instructed to say yes at the exact 
moment the pressure perceived became painful. Each point was recorded three times 
in pre-treatment as well as in post-treatment. The average MPT score for each point in 
pre- and post-treatment was used for statistical analyses. 
 
Muscle strength assessment Eccentric and concentric IPT were measured on the 
same computerised dynamometer as was used for the induction of pain and an 
identical standardisation procedure regarding positioning was followed.  
A warm-up session of two maximum voluntary contractions at the required angular 
velocities was followed by determination of the eccentric and concentric peak torque. 
The first session, at 60°/s, consisted of three repetitions, followed by a 1-min during 
rest, and for the second session, at 120°/s, five repetitions were performed. The 
subjects were instructed to flex and extend the elbow through the entire range of 
motion as forcefully and rapidly as possible for each repetition. The maximum 
eccentric and concentric torque produced during the respective repetitions was used 
for statistical analysis. 
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Light source specifications and treatment procedure 
Light treatment was applied daily according to group allocation. Irradiation occurred 
with an LED device (BIO-DIO preprototype; MDB-Laser, Ekeren, Belgium). The 
probe used emitted infrared light with a wavelength of 950 nm (power range, 80–160 
mW). The area of the probe was 18 cm2 and consisted of 32 single LEDs. The 
frequency was variable within the range of 0–1500 Hz. 
During the complete irradiation procedure, the LED probe was held in contact with 
the skin, perpendicular to the skin surface and at the exact mid-point between the MPT 
mark at 4 cm and the one at 8 cm. Light source properties were identical for all 
subjects of the experimental group and consisted out of irradiation of 6-min lasting 
duration at a continuous power output of 160 mW, resulting in an energy density of 
3.2 J/cm2. To conceal the treated side and condition, the subjects were blinded to the 
treatment status. For the experimental condition a probe was held in contact with each 
arm but only one of the two probes was attached to the LED device. The subjects of 
the placebo group received sham irradiation at both sides. 
The selected parameters are within the scope of previously described light source 
characteristics for pain reduction [1, 28-30] and they are appropriate for the treatment 
of pain in a clinical setting because the duration of the treatment is clinically feasible.  
 
Statistical analysis 
The three outcome measures were analysed separately. For the VAS and MPT 
measurements the same procedure was followed: a general linear model (GLM) for 
repeated measures with two within-subjects factors (time: days 1, 2, 3, and 4 and pre-
post: preceding and following LED irradiation) and one between-subject factor (group: 
placebo or infrared LED irradiated) was performed. If necessary, the GLM was 
followed by appropriate pairwise comparisons (post hoc least significant difference or 
LSD) to determine whether any differences between measurements were statistically 
significant. A similar model was carried out separately for both the treated and the 
control arm. 
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In contrast to MPT and VAS, the muscle strength was analysed differently. The peak 
torque values recomputed towards body weight of the subjects were statistically 
analysed using a GLM for repeated measures. This model consisted of one within-
subject factor (time: day 1, 2, 3, and 4) and one between-subject factor (group: placebo 
or infrared LED irradiated). The model was completed twice, first for the treated arm 
and consequently for the control arm. 
The statistical package for social sciences (SPSS 11.0; SPSS, Inc., Chicago, IL, USA) 
was used for analysis, and statistical significance for all tests was accepted at the 0.05 
level. 
 
RESULTS 
Statistical analysis of all variables of the three outcome measures revealed no significant 
interactive effects of the main interaction (time × group × pre-post). The means and 
standard deviations of the variables for both the treated and the control arm are 
outlined in Table 1 for the VAS, Table 2 for the MPT and Table 3 for the IPT. The 
means of all VAS and MPT variables disclose a non-statistical significant general 
analgesic effect of LED irradiation, conveyed by lower subjective pain rates and higher 
MPT values in the irradiated group than in the placebo group. The lower VAS rates are 
present from day 1 until the last day of the study, but they are more clearly present 
from day 3 pre-treatment. The higher MPT values are present from day 1 post-
irradiation until the last day, and they are more visible at 4 cm, followed by 12 cm and 
finally at 8 cm. In addition to the analgesic influence of LED an increased 
convalescence of muscle strength was noted. It should be remarked that this outcome 
is similar for the treated as well as for the control arm of the irradiated group. The 
findings are also illustrated by Fig. 1, 2, and 3; depicting the time-course for both arms 
of VAS at rest, MPT at 4 cm and IPT for eccentric contraction at 60°/s, respectively. 
Graphical presentation of the other variables shows a similar course. 
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Table 1: Mean scores and standard errors for the visual analog scale of the treated and the control 
arm of the placebo and the LED irradiated group.  
 Day 1 
pre 
Day 1 
post 
Day 2 
pre 
Day 2 
post 
Day 3 
pre 
Day 3 
post 
Day 4 
pre 
Day 4 
post 
Treated arm 
Placebo         
Rest .55±.28 .61±.27 .68±.26 .52±.21 1.25±.42 1.14±.35 .99±.37 .84±.30 
Eccentric .79±.42 1.08±.39 2.67±.38 2.16±.40 3.96±.57 3.84±.51 3.25±.529 2.96±.47 
Concentric .92±.35 1.04±.35 1.76±.34 1.80±.33 3.18±.46 3.13±.40 2.51±.47 2.41±.42 
Irradiated         
Rest .51±.28 .51±.27 .66±.26 .44±.21 .86±.42 .56±.35 .49±.37 .31±.30 
Eccentric .91±.42 .78±.39 2.33±.38 1.91±.40 3.00±.57 2.30±.51 2.22±.529 1.68±.47 
Concentric .82±.35 .74±.35 1.32±.34 1.22±.33 2.08±.46 1.66±.40 1.42±.47 1.03±.42 
Control arm 
Placebo         
Rest .32±.25 .44±.24 .74±.23 .46±.16 1.32±.42 1.05±.34 .88±.37 .68±.24 
Eccentric .64±.42 .64±.32 2.34±.42 1.76±.34 3.55±.48 3.55±.49 3.01±.48 2.8±.43 
Concentric .81±.36 .94±.34 1.84±.33 1.64±.30 3.02±.44 2.72±.42 2.15±.42 2.08±.36 
Irradiated         
Rest .51±.25 .48±.24 .56±.23 .36±.16 .69±.42 .49±.34 .37±.37 .26±.24 
Eccentric .98±.42 .79±.32 2.18±.42 1.95±.34 2.84±.48 2.46±.49 1.72±.48 1.61±.43 
Concentric .89±.36 .70±.34 1.22±.33 1.06.30 1.92±.44 1.61±.42 1.11±.42 .94±.36 
 
Figure 1: Mean visual analog scale (VAS) score (at rest) of the treated and the 
control arm of the placebo and the LED irradiated group, plotted against time 
(day and pre-post) 
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Table 2: Mean scores and standard errors for the mechanical pain threshold of the treated and the 
control arm of the placebo and the LED irradiated group.  
 Day 1 
pre 
Day 1 
post 
Day 2 
pre 
Day 2 
post 
Day 3 
pre 
Day 3 
post 
Day 4 
pre 
Day 4 
post 
Treated arm 
Placebo         
4 cm 15.77±1.47 12.84±1.59 10.45±2.52 11.94±2.37 10.98±1.94 12.01±2.74 14.36±2.17 15.15±2.12
8 cm 17.61±1.47 16.59±1.56 12.89±2.46 13.90±2.45 13.51±1.85 14.21±2.27 17.11±2.05 17.80±2.14
12 cm 17.04±1.84 16.74±2.10 11.19±2.86 12.12±2.80 12.02±2.39 13.09±2.82 15.87±2.45 15.38±2.57
Irradiated         
4 cm 15.15±1.47 18.51±1.59 17.38±2.52 18.52±2.37 17.19±1.94 19.25±2.74 20.04±2.17 20.05±2.12
8 cm 17.08±1.47 16.75±1.56 16.40±2.46 16.82±2.45 14.78±1.85 16.20±2.27 18.24±2.05 19.67±2.14
12 cm 16.97±1.84 17.75±2.10 16.37±2.86 16.42±2.80 15.40±2.39 16.63±2.82 18.64±2.45 20.21±2.57
Control arm 
Placebo         
4 cm 15.56±1.60 12.94±1.77 11.12±2.02 12.46±2.39 10.91±2.29 11.84±2.24 14.34±2.17 14.04±2.08
8 cm 17.68±1.52 16.60±1.49 13.69±2.05 14.16±2.21 13.66±2.06 14.42±2.48 17.83±2.54 17.98±2.09
12 cm 17.32±1.90 15.66±1.90 11.77±2.39 12.92±3.10 12.55±2.48 12.83±2.98 16.71±2.85 15.50±2.49
Irradiated         
4 cm 15.20±1.60 18.50±1.77 15.87±2.02 17.25±2.39 17.18±2.29 17.78±2.24 20.68±2.17 20.26±2.08
8 cm 16.97±1.52 17.52±1.49 15.06±2.05 15.86±2.21 15.63±2.06 16.46±2.48 21.58±2.54 19.58±2.09
12 cm 17.12±1.90 18.35±1.90 14.32±2.39 16.70±3.10 15.55±2.48 17.07±2.98 19.81±2.85 20.56±2.49
 
Figure 2: Mean mechanical pain threshold (MPT) score (at 4 cm) of the treated 
and the control arm of the placebo and the LED irradiated group, plotted 
against time (day and pre-post) 
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Table 3: Mean scores and standard errors for the isokinetic peak torque 
of the treated and the control arm of the placebo and the LED irradiated 
group.  
 Day 1 Day 2 Day 3 Day 4 
Treated arm 
Placebo     
Eccentric 60°/sec .50±.05 .54±.05 .47±.04 .49±.05 
Concentric 60°/sec .43±.04 .39±.04 .40±.04 .40±.04 
Eccentric 120°/sec .45±.04 .48±.04 .48±.05 .46±.05 
Concentric 120°/sec .37±.04 .37±.03 .34±.04 .34±.04 
Irradiated     
Eccentric 60°/sec .50±.05 .57±.05 .54±.04 .58±.05 
Concentric 60°/sec .42±.04 .43±.04 .41±.04 .45±.04 
Eccentric 120°/sec .47±.04 .51±.04 .52±.05 .57±.05 
Concentric 120°/sec .41±.04 .38±.03 .38±.04 .41±.04 
Control arm 
Placebo     
Eccentric 60°/sec .54±.05 .54±.05 .48±.05 .53±.06 
Concentric 60°/sec .44±.04 .45±.04 .40±.04 .43±.05 
Eccentric 120°/sec .49±.04 .54±.05 .48±.05 .51±.04 
Concentric 120°/sec .40±.04 .35±.03 .35±.04 .40±.04 
Irradiated     
Eccentric 60°/sec .55±.05 .54±.05 .57±.05 .59±.56 
Concentric 60°/sec .44±.04 .43±.04 .38±.04 .46±05 
Eccentric 120°/sec .48±.04 .54±.05 .55±.05 .58±.04 
Concentric 120°/sec .38±.04 .36±.03 .42±.04 .43±.04 
 
Figure 3: Mean isokinetic peak torque (IPT) score (eccentric at 60°/s) of the treated 
and the control arm of the placebo and the LED irradiated group, plotted against time 
(day and pre-post) 
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Despite the absence of significant main interaction effects, the remaining interactions 
as well as the main effects were statistically significant for some variables. Only the 
significant interactions including the between-subject factor group as well as the main- 
effect group will be discussed. The other interactions and effects establish the successful 
induction of DOMS but are not relevant in view of the postulated hypothesis. 
The interaction between group and time is significant (p=.014) for the VAS in 
association with full extension for the control arm. Post hoc LSD reveals no difference 
between both groups; a significant effect over time for both groups is found. 
Consequently, this will not be further evaluated. 
A second significant interaction (p=0.002) is the one among the within-subject factor 
pre-post and the between-subject factor group for the MPT at 12 cm for the control arm. 
Post hoc LSD (p=0.001) reveals that the LED-irradiated subjects tolerate more 
pressure after than before the treatment, whereas, in the placebo group, a not 
significant decrease of supported pressure is noted. 
Finally, GLM analysis revealed that, at the treated arm, the irradiated group tolerates 
significantly (p=0.047) more pressure than the placebo group (MPT at 4 cm). 
 
DISCUSSION 
It has previously been demonstrated that the LED source used might assist in 
accelerating wound healing [31], that it has a direct cellular effect [32,33], and that it 
changes nerve conduction characteristics [1]. Nevertheless LED-treated experimental 
induced DOMS, failed to prove the analgesic efficacy of LED at the above-described 
light parameters and treatment procedure. The current outcome concurs with other 
research that demonstrated a lack of effect of various forms of light therapy on DOMS 
[8, 11, 15]. However, despite the absence of an apparent and overall definitive finding, 
the present results cannot exclude favourable effects of LED treatment on pain. Since, 
first of all, an isolated statistical significant pre-post difference between groups (control 
arm, MPT at 12 cm) and a significant group difference (treated arm, MPT at 4 cm) 
revealed that subjects of the irradiated group tolerate more pressure than the subjects 
of the placebo group. Second of all, the overall means identified generally lower VAS 
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scores, higher MPT values and higher peak torques in the irradiated group. This 
implied that the treated subjects experienced noticeable less pain, supported more 
pressure on the painful muscle and generated more force than the non-treated 
participants. However, these results are not statistically significant; consequently, it is 
possible that these differences were found by coincidence and that there is no 
relationship between the treatment and the described results of the three outcome 
measures, though it should be mentioned that the absence of significant findings is 
more probably attributable to the small sample size involved in this study. This 
assumption is based on a post hoc power analysis. It was calculated that for the small 
effect size measured after treatment and for the measured control group event rate a 
sample size of 80 subjects in each group was required, at α=0.05 and power=0.80 
(two-sided), to reveal significant results. 
Another factor conceivably responsible for the lack of solid evidence of the beneficial 
effects of LED treatment upon DOMS-associated pain is related to the size of the 
treatment effect in relation to the severity of the induced DOMS. It is possible that, by 
using multiple exhaustive sets of exercise, severe DOMS were induced which masked 
relatively small but apparent treatment effects [4, 11]. In this same context, it is 
possible that the results only become significantly different after a prolonged treatment 
and follow-up period, as previous research noticed that recuperation subsequent to 
DOMS induction can last up to 10 days [8]. 
 
Although it needs to be stressed that these results are not statistically significant, critical 
analysis of the overall means leads up to three additional remarks. A primary comment 
relates to the pre- and post-treatment courses of the results. Starting at day 2, a clear 
reduction of pain and muscle sensitivity was observed immediately post-treatment. 
Still, one cannot conclude that this is indicative for the analgesic effect of LED 
irradiation as a similar decrease in VAS and increase in MPT values was noted in the 
treated and the control arm of the placebo group. Perhaps this was caused by placebo 
effect, as reported by Pollo et al. [34] the expectation of the participant can easily result 
in pain relief, but it can only be elucidated by implementation of a control group. 
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Nevertheless, in the current study, this particular finding can be most probably 
attributed to the physiological effects of the peak torque measurement, performed 
between the pre- and post-treatment recordings of VAS and MPT, on the painful 
flexor muscle of the upper arm. For the assessment of muscle strength, two short 
series of alternative concentric and eccentric efforts were performed in succession, 
involving elevation of muscle blood flow [20]. Increase of muscle blood flow can assist 
in the removal of inflammatory markers and exudate, consequently reducing local 
tenderness [4]. In addition, the force assessment can be considered as a form of active 
warming-up, resulting in an increased muscle temperature which can reduce muscle 
viscosity [35], bring about smoother muscle contractions and diminish muscle stiffness 
[35,36], thus decreasing the sensitivity of the muscle and moderating pain during 
movement. In any case, the beneficial influence of LED immediately after irradiation 
can not be securely interpreted due to the sequential assessment of the outcome 
measures.  
 
A second additional remark considers the fact that both arms of the irradiated subjects 
demonstrated evidence of the beneficial effects of LED, as a similar reduction of pain 
and muscle sensitivity and higher peak torques were found in course of time at the 
treated arm, as well as at the control arm of the irradiated subjects. This ascertainment 
points to the possibility that infrared LED induces systemic effects [37,38]. Ernst [16] 
stated that in case LED works via systemic effects, the use of the contralateral side as a 
control arm might be ill-advised. Thus reinforcing that future research should include a 
control group to bring clarification [4, 7, 16]. 
 
Finally, it needs to be mentioned that, although the extent of DOMS was probably 
relatively high for investigating the postulated hypothesis, the time-course of the 
present study corresponds to that reported by other investigators [2, 3, 5-10]. 
Significant time effects in many of the variables revealed that muscle damage was 
evident, diffuse muscle soreness became progressively worse 24-48 h after DOMS 
induction, followed by a small amelioration after 72 h [3,5,9,10]. After 72 h, the follow-
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up was ceased; consequently, further regain of force and attenuation of pain and 
muscle sensitivity could not be evaluated. Extending the duration of the assessment 
period could be useful in assessing any longer-term effects of LED treatment, 
particularly because, as mentioned above, differences between both groups are more 
clearly present from day 3 pre-treatment and also because DOMS may last for up to 10 
days when induced with the described protocol [7,15]. 
 
Lack of knowledge regarding both the precise mechanism of action of LED and the 
specific pathophysiology of DOMS hampers the way to offer a definitive explanation 
for the absence of more obvious statistically significant differences. Still the small 
number of significant findings and the mean values suggest that possible analgesic 
effects of infrared LED may not be excluded yet, but to be able to estimate the real 
value of LED further research is necessary. A large-scaled, randomised clinical trial 
which takes the above-mentioned remarks into consideration should be performed. 
 
CONCLUSION 
Regardless of the reasons for the absence of statistical significant effects reported here 
and although LED may have some potential in the management of pain and functional 
impairment associated with DOMS, its effectiveness at the applied densities has not 
been established.  
Future research should focus on evaluation of the appropriateness of DOMS as an 
experimental model of pain and muscle damage. Validation of this model would 
enhance the ability to study various modalities for their potential effects on pain and 
muscle injuries. Besides, the mechanisms of LED action are not known; thus, further 
fundamental investigations need to address the underlying mechanism and 
physiological basis of pain modulation, utilizing LED treatment. 
Once LED irradiation has finally proven its treatment value in an experimental model, 
the most important prospect considers establishing the effectiveness of LED to reduce 
pain in clinical settings.  
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SUMMARY 
As outlined in the general introduction the overall objective of this doctoral thesis is to 
develop the current knowledge about the mechanisms of LED action in view of the 
eventual provision of evidence-based support for the clinical use of LED as a 
biostimulatory and analgesic treatment modality, especially in the field of 
physiotherapy. 
 
Part I: Wound healing 
The investigations described in chapter 1 and 2 were conducted to gain insight into the 
potential biostimulation of LED irradiation under normal in vitro conditions (aim 1). As 
fibroblasts are principal cells for biostimulation (in view of growing and dividing in 
healing wounds), the influence of LED irradiation on fibroblast proliferation was 
assessed.1  
The first investigation consisted of a pilot study, performed in order to evaluate the 
appropriateness of the cell isolation technique, cell culture protocol, and proliferation 
analysis, as well as to appraise the feasibility of the light source properties and 
illumination procedure.  
Data analysis revealed no statistically significant differences between the infrared LED 
irradiated and control petri dishes for the used parameters (table 1). Considering this 
outcome other experimental findings disclose that the absence of stimulatory effects of 
LED irradiation on fibroblast proliferation can partly be attributed to the use of 
inappropriate light source properties. However, the applied external dosimetric 
parameters are well within the recommended spectrum described by previous studies 
investigating fibroblast proliferation influenced by light.2-7 Nevertheless it cannot be 
excluded that changes in the illumination procedure (such as the use of lower power, 
shorter exposure times, wavelengths with finer coverage of the absorption spectrum of 
the irradiated cells, and a longer incubation period between the last irradiation and cell 
counting) could still result in an increased fibroblast proliferation.4,6,7 Of equal 
importance in interpreting the lack of distinctive results are the imperfections of the 
applied proliferation analysis (Bürker hemocytometer). This analysis device entails 
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considerable intervention from the investigator compromising the reliability of the 
method. It is also a time-consuming technique with an insufficient sensitivity for some 
purposes and it shows a considerable variability in intra- and inter-tester cell counts.8-11 
To avoid contamination of the results by these modifiable remarks a similar 
experiment (chapter 2) was performed in which wavelength, power, and output mode of 
the infrared LED source were not modified (table 1); only the exposure time was 
reduced, resulting in a lower radiant exposure. In addition the effect of two other 
emission spectra was evaluated. These probes, emitting red and green light, had a 
shorter wavelength than the infrared LED source and the power was half or a 
sixteenth of the power from the infrared probe. Consequently, the red LED irradiation 
occurred with a different exposure time than the infrared one, in order to attain the 
same radiant exposure (0.53 J/cm2). With respect to the green LED it was not 
endeavoured to achieve the same radiant exposure, as 16 min of irradiation is not 
feasible for in vitro or clinical application. 
Finally, also an LLL light source was integrated. Although it was not attempted to 
analyse the effectiveness of LED in comparison to LLL enclosure of this modality was 
interesting in order to join in with the available literature covering mostly LLL studies. 
To bypass the described problems regarding analysis of fibroblast proliferation, 
counting of the cells was carried out this time by means of a colorimetric MTT assay. 
This method provides more accurate cell counts in a short period of time and therefore 
can be considered as a more reliable alternative to Bürker hemocytometer.11 
MTT assay 24 h after the last irradiation revealed a significantly increased number of 
cells in the irradiated wells in comparison to their (respective sham-irradiated) controls. 
Although the study supplied experimental support for a significantly increased cell 
proliferation by all external dosimetric properties, based on the results of the 
comparative trial with an incubation period of 24 hours, irradiation with the green 
LED source yielded the highest number of fibroblasts. Thus it can be concluded that 
the wavelength of the green LED is probably within the bandwidth of the absorption 
spectrum of some photoacceptor molecules in embryonic chicken fibroblasts and that 
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the chosen dosimetric parameters are largely apposite to irradiate monolayer fibroblast 
cultures in vitro.6,12  
 
Table 1: External dosimetric properties summarized for each chapter 
  Wavelength Power Exposure time 
Output 
mode 
Radiant 
exposure 
PART I       
Chapter 1       
In vitro 
part 
LED-infrared 950 nm 160 mW 6 min continuous 3.2 J/cm2 
In vivo part LED-infrared 950 nm 160 mW 6 min continuous 3.2 J/cm2 
Chapter 2       
 LED-infrared 950 nm 160 mW 1 min continuous 0.53 J/cm2
 LED-red 660 nm 80 mW 2 min continuous 0.53 J/cm2
 LED-green 570 nm 10 mW 3 min continuous 0.1 J/cm2 
 LLL 830 nm 40 mW 5 sec continuous 1 J/cm2 
Chapter 3       
 LED-green 570 nm 10 mW 3 min continuous 0.1 J/cm2 
PART II       
Chapter 4       
 LED-infrared 950 nm 160 mW 2 min continuous 1.07 J/cm2
Chapter 5       
 LED-infrared 950 nm 160 mW 6 min continuous 3.2 J/cm2 
 
The next aim of the first part of this doctoral thesis was to explore whether LED 
treatment could ameliorate in vitro cell proliferation under conditions of impaired 
healing. In the pursuit of this aim fibroblasts were cultured in medium supplemented 
with glucose -mimicking cell proliferation in diabetic patients (chapter 3). Based on a 
pilot study the amount of glucose necessary to inhibit normal growth was determined. 
In order to attain an important reduction of cell viability and decreased proliferation 
rate, a relatively high concentration of glucose (166.7 mM) was necessary in 
comparison to the in vivo concentration in conditions of severe diabetic hyperglycaemia 
(20-40 mM).13-16 This is in essence a consequence of the glucose exposure dissimilarity 
between both circumstances: in vitro limited to 72 h, whereas the human tissue of a 
diabetic patient in vivo is chronically exposed to glucose. 
Treatment of the fibroblasts occurred in respect of the previously described results 
with the same irradiation parameters and illumination procedure (chapter 2). 
Accordingly, green LED irradiation, labelled as the most appropriate treatment for 
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irradiation of a monolayer fibroblast culture in vitro, was used at an equal dosage as in 
the previous study (table 1).  
Analysis of the cell proliferation, by means of MTT measurements, yielded a 
significantly higher rate of proliferation in hyperglycaemic circumstances after 
irradiation than in the control conditions (i.e. hyperglycaemic circumstances without 
irradiation). Thus this outcome supported the stimulatory potential of green LED 
irradiation on fibroblast proliferation and cell viability of fibroblasts cultured in a 
considerable destructive hyperglycaemic medium. 
 
Finally, although the results of the in vivo part of chapter 1 were persuasive and 
encouraging, they will not be further discussed in this summary of part I as it was not 
aimed in this doctoral thesis to investigate the wound healing process in vivo. However, 
the results of this case study can be a valuable hold for future in vivo research. 
The possible clinical implications of these results and future research directions in the 
scope of wound healing will be discussed below.  
 
Part II: Analgesia 
In the second part, two studies investigated the effects of LED irradiation as a 
potential intervention mode in one of the most important fields in physiotherapy 
practice: analgesia. Chapter 4 describes the influence of LED treatment on changing 
sensory nerve conduction characteristics of a human superficial peripheral nerve. 
Altering nerve conduction characteristics may not be the sole beneficial purpose to 
attain with LED irradiation in view of analgesia; but the advantage of nerve conduction 
characteristics is that they are objective measurable physical variables and changes in 
these characteristics provide a potential explanatory mechanism of pain inhibition by 
LED treatment.17 
The results showed that percutaneous LED irradiation, at feasible clinical parameters, 
can generate a significant decrease in NCV and increase in NPL for all recordings post-
treatment in comparison to the baseline measurement. The data in the placebo group 
did not reveal any significant difference in the same course of time. Statistical analysis 
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revealed significant differences between the experimental and the placebo group for 
NCV as well as for NPL at all time-points of observation, with exception of the NPL 
recording immediately after finishing irradiation.  
It was also observed that the noted effects did not weaken as time progressed. It can 
be concluded that post-treatment conduction measurements should be extended in 
time, which is in accordance with the findings of some previous studies.18-21 Clarifying 
the point of time at which the effect extinguishes is necessary and clinically relevant 
when treating pain by means of LED irradiation. Besides obtaining the desired 
neurophysiological effects, ideally, the optimal irradiation parameters should be 
applied. The most favourable dosimetric properties are not yet determined, but based 
on this study and previously described assays it can be speculated that the dosimetric 
window is quite large. 
Regardless of these clinically important remarks, the present findings allow to draw the 
following conclusion: LED irradiation at clinically applied densities can generate an 
immediate and localized effect upon conduction characteristics in underlying nerves as 
LED treatment results in lowering the NCV and augmenting the NPL. Therefore, the 
outcome of this in vivo experiment assumes a potential pain relief by means of LED 
treatment and justifies further research regarding its clinical effectiveness in laboratory 
settings and at a clinical level. 
 
The fourth and final aim was to determine the efficacy of LED irradiation as an 
analgesic treatment modality in a laboratory setting. In pursuit of this aim chapter 5 
illustrates a clinical study observing the effect of LED treatment on a model 
comprising experimentally induced DOMS in a healthy population. The progress of 
pain perception and peak torque was evaluated during 4 consecutive days commencing 
on the day of DOMS induction. The effect of infrared LED treatment, at the light 
parameters described (table 1), was assessed with regard to three different factors: time 
(day 1, 2, 3, and 4), pre-post (preceding or following LED irradiation), and group 
(placebo or experimental). Statistical analysis of all variables of the 3 outcome measures 
(VAS, MPT, and IPT) revealed no significant interactive effects of the main interaction 
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(time*group*pre-post). For the remaining interactions and for the main effects only a 
few significant findings were relevant in view of the postulated hypothesis. 
Notwithstanding the absence of an apparent and overall statistically significant finding, 
the present results indicate favourable trends of LED treatment on pain as the means 
of all VAS and MPT variables show a statistically nonsignificant general analgesic 
effect of infrared LED irradiation, expressed by lower subjective pain rates and higher 
MPT values in the irradiated group. In addition to the analgesic influence of LED an 
augmented restoration of muscle strength was noted. The lack of solid, statistically 
significant evidence for these beneficial effects of LED treatment upon DOMS-
associated pain can possibly be attributed to the small sample size in this study or even 
to the size of the treatment effect in relation to the severity of the induced DOMS, as 
induction of severe DOMS can mask relatively small but apparent treatment 
effects.22,23 A final possibility is that the results only become significantly different after 
a prolonged treatment and follow up period as previous research demonstrated that 
recuperation subsequent to DOMS induction can last up to 10 days.24 
It should also be noted that the described general analgesic effect of LED irradiation 
was identical for the treated as well as for the control arm in the irradiated group, 
proposing that infrared LED might induce systemic effects. 25,26 However it needs to 
be stressed that these results were not statistically significant. 
Regardless of the absence of statistically significant findings, the mean values suggest a 
potential role for infrared LED irradiation in the management of pain and functional 
impairment associated with DOMS. Notwithstanding this postulation, future research 
is absolutely required to establish the effectiveness of LED treatment to reduce pain, as 
well at the applied densities as for other dosimetric parameters. 
 
CLINICAL IMPLICATIONS AND FUTURE RESEARCH DIRECTIONS 
In the course of the past years, during the process of the genesis of this thesis, 
therapeutic physical agents in general and phototherapeutic modalities in particular 
became less important as physiotherapeutic modes of treatment than during the 
preceding two decades. The diminished use of these treatment modalities in the 
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physiotherapy practice is to a certain degree a consequence of the controversial 
research findings regarding the use of these physical agents. This issue of controversy 
led to less support for the use of these treatment modalities and a growing scepticism 
regarding the effectiveness of these physical agents within the scope of the growing 
climate of evidence-based practice. A second responsible protagonist for the loss of 
popularity of physical agents is linked with the current tendency within physiotherapy, 
emphasising active remedial therapy. The establishment of this development was based 
on various experiments, mainly performed during the last decade, demonstrating that 
active treatment modalities are for numerous impairments and disabilities preferable to 
more passive forms of therapy. In Belgium the prevailing nomenclature, which came 
into use on 1 May 2002, went along with this tendency. In the appendix to the Royal 
decree of 14 September 1984 towards settlement of the nomenclature of medicinal 
treatments concerning compulsory insurance for medical care and allowances, the 
personal involvement of the physical therapist during the physiotherapeutic session 
was emphasized and it was even defined that massage, physical techniques within the 
framework of electrotherapy, ultrasonic therapy, laser therapy and several other techniques for thermal 
application, can only be remunerated when they are applied supplementarily and not as a  sole therapy. 
This implies that passive treatment modalities should not be used as sole method of 
treatment and should always be considered as an adjunct to an active treatment 
program. This development needs to be applauded in many cases such as various 
painful musculoskeletal problems, functional instability, rehabilitation of neurological 
patients, re-activation of the elderly population, psychomotor rehabilitation, 
cardiovascular, and respiratory convalescence. Nevertheless it would be erroneous to 
entirely reject physical agents, including LED treatment. Based on the findings of the 
above described experiments it needs to be stressed that for some purposes, especially 
within the scope of impaired wound healing, LED irradiation could be a suitable 
therapeutic measure. This statement is founded on the results of part I of the present 
thesis; they provided satisfactory fundamental evidence for the advantageous effects of 
LED treatment on a crucial exponent of the wound healing process, namely fibroblast 
proliferation. The beneficial findings are the result of basic in vitro research. As it is 
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inaccurate to simply extrapolate these results to the clinical practice, the clinical use of 
LED irradiation for wound healing needs to be preceded by purposive and specific in 
vivo investigations to substantiate these basic research findings.27 
The case study described in chapter 1 indicates a foundation for further in vivo research. 
Visual appraisal of the surgical incision revealed (from the 65th day in the course of the 
reparative process onwards) that the irradiated area -which initially showed inferior 
epithelialization and wound contraction- showed a more appropriate contracture than 
the control area, characterized by less discoloration at scar level and a less hypertrophic 
scar. These clear beneficial effects of LED treatment on a human cutaneous wound 
can serve as preliminary impetus for further research into the clinical applicability of 
LED therapy, although this case study is insufficient in order to guarantee a safe, 
correct and effective use of LED as a therapeutic modality.  
Despite these remarks it tentatively can be concluded that, based on a detailed analysis 
of the available data of the present in vitro studies and the given case report, in 
combination with the small number of previously published human studies, the 
beneficial effects of LED irradiation at the cellular level are obvious and therefore a 
potentially favourable outcome can be assumed in clinical practice.28-30 LED-
modulated stimulation of wound healing can be gradually and vigilantly implemented 
clinically. Nevertheless the real benefits of LED irradiation within the scope of wound 
healing can only be established by additional clinical trials, as thus far clinical 
application and stipulation of dosimetry still occurs on a trial-and-error basis, which is 
not conducive to a generally accepted clinical use of LED. To lend more credibility to 
the treatment of wounds by means of LED irradiation and to expel the existing 
controversy and scepticism surrounding this topic, in vivo investigations on wound 
healing using a number of different animal models, and adequately controlled human 
studies are necessary. In addition, these studies should be performed preferably on a 
population suffering from impaired healing as a consequence of diabetes mellitus or as 
a result of any other debilitating reason; because as posed by Reddy et al31,32 and as 
mentioned above, light has possible optimal clinical effects in the treatment of healing-
resistant wounds.  
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Drawing general conclusions and formulating clinical implications for analgesia is 
obviously less manifest, first of all because only a limited number of possible 
mechanisms of action in order to obtain analgesia were highlighted and secondly 
because both studies did not come to a joint or complementary conclusion. The 
outcome of the first study revealed that LED treatment lowers the NCV and augments 
the NPL resulting in a slower stimulus conduction and consequently a reduced number 
of sensory pulses per unit of time. Thus, it could be assumed that LED induces pain 
relief, but the results of the study describing the effect of LED treatment on 
experimentally induced DOMS failed to prove the analgesic efficacy of LED therapy.  
In addition, it needs to be emphasised that the first study (chapter 4) measured the effect 
of LED irradiation on the large myelinated Aβ afferents. A noteworthy question and 
meanwhile a stimulus for future investigation, is whether the measured effects can be 
extrapolated from these sensory nerve fibres to the actual nociceptive afferents, 
notably the myelinated Aδ-fibres and unmyelinated C-fibres. The functional testing of 
these nociceptive pathways relies on laser-evoked potentials which selectively activate 
Aδ-fibres and C-fibres.33,34 This technique was presently not available, therefore a 
standard sensory nerve conduction study was performed.  
 
Whereas stimulation of wound healing by means of LED irradiation can be cautiously 
implemented in the clinical practice, at this stage it is too early to promote LED 
irradiation as a treatment modality for pain. To make this possible it is essential to 
conduct numerous studies with regards to the use of LED in the field of analgesia. 
Future research should focus on fundamental investigations in order to discover the 
underlying mechanisms and physiological basis of pain modulation utilizing LED 
treatment. Furthermore the evaluation of the appropriateness of DOMS as an 
experimental model of pain is an important prospect to consider, as validation of this 
model would enhance the ability to study various modalities for their potential effects 
on pain. Irrespective of the difficulties regarding standardisation of the research 
population and evaluation of soreness, inextricably linked with clinical pain studies, the 
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ultimate objective of future research should be the establishment of the effectiveness 
of LED irradiation to reduce pain of miscellaneous origin in a clinical setting. 
 
Regardless of the encouraging results of the described studies and besides the earlier 
proposed, specific directions for future research (directed towards wound healing or 
pain relief), it is necessary in the interest of the patient’s well being and to the 
advantage of the prospective clinical use of LED to highlight a few more issues for 
future research. Therefore one has to deal with some limitations of the performed 
investigations. A first limitation concerns the fact that only two mechanisms of LED 
action were investigated (notably changed fibroblast proliferation and alteration of the 
nerve conduction characteristics). So, one can conclude that for further and better 
understanding of the mechanisms of action it is necessary to perform more basic 
research. Answering the questions regarding the functioning of LED irradiation will 
simplify the evaluation and reinforce the interpretation of the obtained results and 
ultimately contribute to a more widespread and well definded acceptance of the use of 
LED in clinical settings. 
A second general limitation of this doctoral thesis is the substantial difference in the 
used external dosimetric parameters between the different chapters and even within 
one and the same study (illustrated in table 1); this complicates the comparison 
between the different trials. In each trial the dosimetry was individually ascertained, 
based on previous studies within the given field. As not for every application the same 
dosimetry is suggested in literature, a range of dosages were used. Another important 
factor in deciding on the dosimetry was the clinical applicability of the dosage, as it is 
useless to investigate the appropriateness of a treatment modality at a clinically 
unrealistic dose. As a result of this limitation, the current findings do not fully 
contribute to the explanation regarding the ideal parameters one should use, although 
this was not set as a principal purpose. Based on this thesis and previously described 
assays it can be speculated that the possible window for these parameters is quite large; 
the ideal irradiation parameters and proper timing or sequencing of LED irradiation 
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for example to the various phases of wound healing and to different painful conditions 
are therefore possibly unattainable. 
The establishment of an appropriate dosimetry should also consist of investigating the 
absolute and relative penetration depth of LED irradiation into human tissue. This is 
less crucial within the scope of wound healing, but it is of key importance while 
treating deep-seated tissue (eg: nerve fibres, muscles, circulatory components, et 
cetera). 
Finally, this thesis only investigated the efficiency of LED in a very limited number of 
conditions, notebly wound healing and pain. Within the scope of physiotherapy and 
medicine in general, there are numerous other purposes for which LED irradiation is 
promoted such as oedema, arthritis, miscellaneous orthodontic applications, seasonal 
affective disorder, neonatal jaundice, photodynamical therapy, et cetera.28,35-41  
 
In summary additional work on establishing proper dosimetry and identifying the 
biochemical or photobiologic phenomena that are responsible for improving wound 
healing and reducing pain or even other effects within a broader spectrum of 
conditions, remains to be done in order to answer unreciprocated questions. Until that 
time, the potential clinical usefulness and actual value of LED irradiation for wound 
healing and even to a larger extent for analgesia should always be approached with 
appropriate professionalism and even caution. 
 
FINAL CONCLUSION 
LED devices are promoted for clinical use, but the currently available scientific 
documentation regarding effectiveness of this physical agent is rather scarce. Through 
providing scientific support for the biostimulatory and analgesic effectiveness of LED 
irradiation, this doctoral thesis attempted to bridge in some degree this gap.  
 
The conducted studies revealed that LED irradiation undeniably has potential 
beneficial effects on wound healing and to a lesser degree within the scope of 
analgesia. However, based on the present results it can be corroborated that light 
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therapy, in the guise of LED irradiation, is not magic, but these results can raise some 
corrective doubts in fundamental disbelievers and antagonists. 
Nevertheless, we have to join the queue of scientists who have found beneficial results, 
but cannot elucidate with certainty how this outcome was established. Thus, although 
the present results are encouraging, a continuing development and integration of new 
knowledge based on further research is necessary in various domains of intervention. 
Therefore, several directions for future investigations were proposed in order to cover 
as many existing gaps and to answer the utmost number of remaining questions as 
possible. Still one ought to be aware not to carry future fundamental research at a 
disproportional level and the inevitable quest for mechanisms of LED action should 
not hypothecate the potential clinical value; implying that at a certain point it should be 
appropriate to make the transfer from science to the application of the available 
knowledge in clinical practice. 
 
The described findings, regarding LED irradiation, are comparable to the results of 
previously published studies performed with other light sources. Consequently, as 
postulated by some LED providers, it can be speculated that the biological response of 
tissue to light irradiation can probably not be equated merely to a light source, but 
rather to a broad photo-energy window. 
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Het medicinale gebruik van licht met therapeutische doeleinden gaat ver terug in de 
tijd. Ook in het domein van de kinesitherapie zijn hiervan duidelijke sporen terug te 
vinden met vooreerst de toepassing van ultraviolette (UV) stralen en later de applicatie 
van laagvermogen laserlicht (LVL) ter behandeling van een gamma aan aandoeningen. 
Vandaag is het gebruik van UV-licht in de kinesitherapie nagenoeg verdwenen en rest 
enkel nog de sporadische klinische toepassing van LVL. Deze tanende populariteit is 
ongetwijfeld terug te koppelen aan een mentaliteitsverandering op klinisch, zowel als 
op wetenschappelijk vlak. Klinisch is er duidelijk sprake van het toenemende belang 
van de actieve betrokkenheid van de patiënt in zijn herstelproces waardoor passieve 
interventies zoals lichttherapie, elektrotherapie en massage geleidelijk in onbruik raken. 
Deze klinische tendens is onlosmakelijk verbonden met het hedendaagse klimaat van 
“op evidentie gestoelde” strategieën en daarin blijken deze passieve therapievormen 
moeilijk te verantwoorden.  
Deze passieve interventies werden ontwikkeld en geïntroduceerd in een periode waarin 
de vooropgestelde wetenschappelijke eisen duidelijk secundair waren aan andere 
overtuigingen en belangen. Het ongeloof en scepticisme (gevoed vanuit 
methodologische tekorten, nauwelijks reproduceerbare onderzoeksdesigns, gebrek aan 
consistente resultaten en ongebreidelde indicatie-extrapolatie naar klinische settings) in 
de academische wereld aangaande bijvoorbeeld het klinisch gebruik van laagvermogen 
laser, vormden aldus geen rationele hinderpaal voor een veralgemeende aanvaarding in 
de kinesitherapie. Recente rigoureuze (meta)analyses stellen deze mentaliteit vandaag 
aan de kaak en leiden onherroepelijk tot het verlaten van heel wat passieve interventies, 
inclusief het gebruik van licht.  
Deze mentaliteitswijziging is op zich toe te juichen, maar impliceert ook het risico dat 
de potentiële klinische waarde van bijvoorbeeld laser voor selectieve en onderbouwde 
doelstellingen of indicaties, waarvoor wel evidentie kan worden aangeleverd, in één en 
dezelfde pennentrek worden opgeofferd. Een typisch gevolg wanneer bewijskracht 
komt na de commercialisatie en zo het spreekwoordelijke kind met het badwater wordt 
geloosd.  
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De technologie stond intussen niet stil en de ontwikkeling van nieuwe ‘therapeutische’ 
lichtbronnen bleef evolueren zodat vandaag ook light emitting diodes (LEDs) en 
gepolariseerd licht als fysische bronnen kunnen worden aangewend. Teneinde te 
anticiperen op het gekenschetste karakteristieke verloop en jammerlijke herhalingen te 
voorkomen, lijkt een gerichte en rationele a priori aanpak, conform de 
wetenschappelijke eisen van het huidig medisch klimaat, absoluut aangewezen.  
Te meer daar grondige literatuurstudie leert dat men, ten behoeve van de 
werkingsmechanismen en effectiviteit van deze recente toepassingen van lichttherapie, 
zich beroept op dezelfde (soms gecontesteerde) onderzoeken van laagvermogen laser. 
De fysische verschillen tussen LED en LVL laten bovendien vermoeden dat de 
extrapolatie vanuit deze literatuur ten onrechte gebeurt en dat voorzichtigheid hierbij is 
geboden. De introductie van alternatieve lichtbronnen in de huidige 
kinesitherapeutische praktijk, met voornamelijk LEDs, blijkt dus wetenschappelijk 
weerom nagenoeg niet onderbouwd en de nakende commercialisatie dreigt aldus 
eenzelfde bedenkelijke levenscyclus van deze lichtbronnen te gaan induceren. Nood 
naar specifiek wetenschappelijk onderzoek met betrekking tot het evidence-based 
gebruik van LEDs in de kinesitherapie is dan ook bijzonder pertinent, in het bijzonder 
binnen de domeinen van haar potentieel beloftevolle klinische toepassingen: 
wondheling en analgesie. 
 
Een eerste deel van dit doctoraal proefschrift handelt over de invloed van LED op de  
wondheling. Aan de hand van drie in vitro onderzoeken die werden uitgevoerd op 
prominente protagonisten van de wondheling, de fibroblasten, werd getracht het 
fundamenteel biostimulatoir effect van LED bestralingen te beoordelen. Fibroblasten 
zorgen voor de vorming van een essentiële bindweefselmatrix, die onderzoek naar de 
proliferatie van deze cellen cruciaal maakt in het kader van wondheling. Dit opzet werd 
respectief geconcretiseerd onder normale in vitro omstandigheden en in een toestand 
waarbij de normale celgroei werd verstoord.  
In een eerste onderzoek (hoofdstuk 1) werd aan de hand van Bürker hemocytometrie het 
effect van LED op de proliferatie en viabiliteit van fibroblasten nagegaan. Statistische 
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data-analyse leverde geen significante resultaten op. Dit kan mogelijk enerzijds worden 
verklaard door het gebruik van een inadequate LED dosering en anderzijds een 
methodologisch cruciaal storende factor, de evaluatiemethode. Bürker hemocytometrie 
vergt namelijk een aanzienlijke en tijdrovende interventie van de onderzoeker wat de 
precisie en betrouwbaarheid van de techniek hypothekeert, met een grote intra- en 
inter-tester variabiliteit tot gevolg. 
In een poging aan deze kritische bemerkingen tegemoet te komen, werd hetzelfde 
onderzoek gereproduceerd (hoofdstuk 2) met weliswaar modificatie van de 
bestralingsparameters (dosering). De effecten van de drie verschillende LED 
golflengtes en één LVL lichtbron op de proliferatie en viabiliteit van de fibroblasten 
werden hierbij geanalyseerd door middel van een meer betrouwbare en minder 
subjectieve analyse, de colorimetrische meting op basis van 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide (MTT). 
De studieresultaten uit dit gemodificeerd design toonden het significant biostimulatoir 
effect van alle LED doseringen aan, evenals van de LVL bron. Deze data vormden 
tevens een basis voor meer coherente en relevante inzichten aangaande de globale 
bestralingsparameters (golflengte, stralingsintensiteit en stralingsduur). 
 
Gezien de stimulatie van de wondheling in se pas geïndiceerd is in condities waarbij het 
wondhelingsproces verstoord verloopt en bijgevolg een chronisch en invaliderend 
karakter dreigt te kennen en pas in dergelijke omstandigheden een biostimulatoire hulp 
rechtvaardigt, werd in een derde fase het in vitro onderzoek onder gemanipuleerde 
vorm uitgevoerd ter enscenering van een verstoord helingsproces (hoofdstuk 3). De 
fibroblasten werden hierbij gecultiveerd in een gemodificeerd cultuurmedium met 
extreem hoge concentraties glucose. Deze modificatie van het medium staat model 
voor de celproliferatie bij de diabetespatiënt, een populatie waarbij in de klinische 
praktijk de stimulatie van het wondhelingsproces een klinisch relevante interventie kan 
vormen. Ook onder deze hyperglycemische omstandigheden vertoonde LED, met de 
gehanteerde parameters, gunstige cellulaire effecten op het vlak van viabiliteit en 
proliferatie 
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Het tweede deel van dit proefschrift exploreert het domein van het potentieel 
analgetisch effect van LED binnen de kinesitherapie aan de hand van twee 
fundamentele onderzoeken. 
In het eerste onderzoek (hoofdstuk 4) werd het effect nagegaan van LED op de perifere 
sensorische zenuwgeleidingskarakteristieken van de nervus suralis. Als experimentele 
hypothese werd vooropgesteld dat LED een daling van de zenuwgeleidingssnelheid en 
een stijging van de negatieve pieklatentie veroorzaakt, wat een mogelijke neurale 
verklaring van een analgetisch effect van het medium zou kunnen belichamen. 
Hiervoor werden de resultaten van een eerste, antidrome elektroneurografische (ENG) 
meting vergeleken met de resultaten van een identieke ENG meting, uitgevoerd op vijf 
verschillende tijdstippen (0, 2, 4, 6 en 8 min) na LED bestraling. De resultaten tonen 
aan dat percutane LED bestraling, onder de gehanteerde parameters, een onmiddellijke 
significante daling van de zenuwgeleidingssnelheid en gelijktijdig een stijging van de 
negatieve pieklatentie genereert, overeenkomstig met de geponeerde experimentele 
hypothese. 
 
Een tweede studie (hoofdstuk 5) evalueerde de effectiviteit van LED als pijnstillend 
fysisch agens bij een experimenteel geïnduceerd pijnmodel waarbij musculoskeletale 
pijn en stijfheid centraal staan: delayed-onset muscle soreness (DOMS). Met behulp 
van een gestandaardiseerd protocol voor een isokinetisch concentrisch/excentrische 
krachtsinspanning, werden DOMS uitgelokt. Na inductie van DOMS werd een LED 
behandeling (met een klinisch haalbare dosering) uitgevoerd. De behandeling werd vier 
keer herhaald, met een interval van 24 h tussen elke behandeling. Het effect van LED 
op het verloop van DOMS werd in de loop van deze periode (4 dagen) geëvalueerd 
(zowel voor als na de LED behandeling) aan de hand van een gestandaardiseerde 
isokinetische krachtmeting en een registratie van de waargenomen spierpijn. De 
spierpijn en -gevoeligheid werd beoordeeld via een visueel analoge schaal en met 
behulp van een kwantitatieve hand-hold algometer.  
Analyse van de bekomen data bracht geen significante verschillen tussen de 
controlegroep en de experimentele groep aan het licht. Op basis van de gemiddelden 
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kon descriptief en zonder statistische pretenties voorzichtig worden afgeleid dat LED 
behandeling gunstige effecten bleek te genereren ten overstaan van de recuperatie van 
de spierkracht, de mate van spiergevoeligheid en de hoeveelheid pijn die door de 
proefpersonen werd waargenomen gedurende de evaluatieperiode. De algemene 
afwezigheid van significanties kan mogelijk worden verklaard door de relatief kleine 
proefgroep die werd onderzocht en/of door de grootte van het behandeleffect in 
verhouding tot de ernst van de geïnduceerde DOMS. Ernstige DOMS kunnen immers 
een aanwezig behandeleffect gemakkelijk maskeren. Een uitbreiding van de follow-up 
kan hierbij eventueel een oplossing bieden. Gezien de resultaten is hier evenwel 
absolute omzichtigheid geboden en moet deze visie louter als speculatief worden 
beschouwd. 
 
Als gevolg van de beschreven klinische en wetenschappelijke trends binnen de 
kinesitherapie, is het gebruik van fysische middelen en lichttherapie in het bijzonder de 
laatste jaren aanzienlijk afgenomen.  
De positieve resultaten van de verschillende in vitro studies in het kader van wondheling 
vormen een cruciale en belovende voedingsbodem opdat ook de klinische toepassing, 
vooral bij (diabetes)patiënten met chronische -slecht helende- wonden, potentieel 
gunstige resultaten kan opleveren. Bijgevolg vormt het eerste deel van dit doctoraat een 
belangrijke basis tot design voor verder in vitro maar vooral ook klinisch onderzoek.  
Gelijkaardige besluitvorming met betrekking tot analgesie is een meer delicate kwestie. 
Er werden immers slechts een beperkt aantal aspecten van het pijnmechanisme 
onderzocht en bovendien kwamen beide studies niet tot een eenduidig, noch 
complementair resultaat. Verder onderzoek ter exploratie van de mogelijke 
onderliggende mechanismen en fysiologische basis voor pijnmodulatie is daarom 
onontbeerlijk om de klinische toepassing van LED in het kader van pijnstilling op 
termijn wetenschappelijk te rechtvaardigen.  
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LED: tovenarij, trend of therapie?  
LED mag geen magische krachten worden toegemeten maar verdient het lot van een 
kort leven en een vroegtijdige dood niet. De onderzoeksresultaten vormen een 
wetenschappelijk platform opdat LED binnen de kinesitherapie de kans zou krijgen 
zich te ontwikkelen tot een therapie, maar weliswaar voor relevante en heel specifieke 
indicaties.  
 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Light thinks it travels faster than anything but it is wrong. No matter how fast light travels, it finds 
the darkness has always got there first, and is waiting for it 
(Terry Pratchett, Reaper Man, 1991) 
   
 
